Next Article in Journal
A Randomized Trial on Resveratrol Supplement Affecting Lipid Profile and Other Metabolic Markers in Subjects with Dyslipidemia
Previous Article in Journal
Early Naso-Gastric Feeding and Outcomes of Anorexia Nervosa Patients
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Dietary Phytochemicals as Potential Chemopreventive Agents against Tobacco-Induced Lung Carcinogenesis

1
College of Pharmacy, Ningxia Medical University, 1160 Shengli Street, Yinchuan 750004, China
2
Department of Medicinal Chemistry, University of Florida, 1345 Center Drive, Gainesville, FL 32610, USA
3
School of Pharmacy, Second Military Medical University, 325 Guohe Road, Shanghai 200433, China
*
Authors to whom correspondence should be addressed.
Nutrients 2023, 15(3), 491; https://doi.org/10.3390/nu15030491
Submission received: 3 November 2022 / Revised: 23 December 2022 / Accepted: 14 January 2023 / Published: 17 January 2023
(This article belongs to the Section Phytochemicals and Human Health)

Abstract

:
Lung cancer is the second most common cancer in the world. Cigarette smoking is strongly connected with lung cancer. Benzo[a]pyrene (BaP) and 4-(N-methyl-N-nitrosamine)-1-(3-pyridyl)-butanone (NNK) are the main carcinogens in cigarette smoking. Evidence has supported the correlation between these two carcinogens and lung cancer. Epidemiology analysis suggests that lung cancer can be effectively prevented through daily diet adjustments. This review aims to summarize the studies published in the past 20 years exploring dietary phytochemicals using Google Scholar, PubMed, and Web of Science databases. Dietary phytochemicals mainly include medicinal plants, beverages, fruits, vegetables, spices, etc. Moreover, the perspectives on the challenges and future directions of dietary phytochemicals for lung cancer chemoprevention will be provided. Taken together, treatment based on the consumption of dietary phytochemicals for lung cancer chemoprevention will produce more positive outcomes in the future and offer the possibility of reducing cancer risk in society.

1. Introduction

Lung cancer is the second most common cancer in the world. Its mortality in the past four decades was 59.0/100,000 person-years. Lung cancer was the leading cause of cancer death in 2020, representing approximately one in 10 (11.4%) cancers diagnosed and one in 5 (18.0%) deaths [1]. Meanwhile, the 5-year survival rate was less than 21% [2]. In 2022, approximately 350 Americans die from lung cancer every day [3]. In China, lung cancer is the most common cancer among males (50.04/100,000) and the second in females(23.63/100,000) [4]. The major types of lung cancer have been divided into small-cell lung carcinoma, and non-small cell lung cancer (NSCLC). NSCLC includes adenocarcinoma, squamous cell carcinoma, small cell, and so on. The occurrence of lung carcinogenesis is multifactorial. However, in most cases, it is due to familial inheritance and the epigenetic damage caused by long-term exposure to carcinogens. Besides, gene mutation could lead to the docking of downstream molecular signals and related protein changes and eventually lead to the occurrence of lung tumors. For example, EGFR (epidermal growth factor receptor, which plays an important role in the cancer process) activated mutations lead to constitutive tyrosine kinase activation and oncogenic transformation of lung epithelial cells [5]. Currently, there are many treatment strategies for lung cancer. Nowadays, immunotherapy, especially for programmed death-1 (PD-1)/PD-L1 blockade immunotherapy, as monotherapy, or combined with chemotherapy is the standard of care. However, for patients without an actionable driver mutation and when targeted therapies are not available, chemotherapy (in combination with radiotherapy) has been the standard of care, especially for advanced NSCLC [6]. Surgical resection is preferred for stages I through IIIA NSCLC. About 40% of the new diagnoses of cancer are in an advanced stage [7]. Therefore, the prevention of lung cancer needs more attention because of the poor survival rate.
According to AACR CANCER PROGRESS REPORT 2022, tobacco use is one of the main preventable causes of cancer. Smoking contributed to more than 64 percent of deaths of tracheal, bronchus, and lung cancers. For lung cancer, it is estimated that 90% of lung carcinomas are directly due to smoking and smoking-derived carcinogens. Consequently, the best means for preventing lung carcinoma is to avoid exposure to cigarette smoke [8]. It is worth mentioning that not all kinds of lung cancer are caused by smoking, especially for some Asian women. That is because of the activated mutation of EGFR [9]. Tobacco smoke consists mainly of nicotine, benzo[a]pyrene (BaP) and 4-(N-methyl-N-nitrosamine)-1-(3-pyridyl)-butanone (NNK) (for chemical structures, see Figure 1), which are highly toxic and can lead to health problems such as lung cancer. At present nicotine has not been identified as a carcinogen. However, nicotine addiction is a major contributor to persistent exposure to other carcinogens in the smoker. Moreover, nicotine has the effect of inducing chemotherapeutic drug resistance and activating nicotinic acetylcholine receptors to accelerate the development of cancer, making the treatment of patients with lung cancer less effective than expected [10]. BaP is one of the most studied polycyclic aromatic hydrocarbons, which has potent carcinogenicity, teratogenicity, and mutagenicity. Exposure to BaP has three significant routes, which are skin exposure, dietary intake, and inhalation. BaP is hydrophobic and readily crosses the cell membrane and binds to receptors. For instance, BaP could activate and up-regulate the expression of aryl hydrocarbon receptor (AhR) in lung adenocarcinoma [11]. It forms an intracellular complex with AhR that induces the expression of cytochrome P450 to stimulate its metabolism [12]. Benzo[a]pyrene-7,8-diol-9,10-epoxide (BPDE), a metabolite of BaP, could produce DNA damage and form BPDE-adducts [13]. Smokers tend to develop lung cancer when they are exposed to NNK. For the smoker, NNK absorption is regulated mainly by direct inhalation of mainstream smoke [14]. Non-smokers could be exposed to NNK by second-hand smoke and side-stream smoke from the smoldering tobacco product, and even dermally via NNK-contaminated surfaces [15]. Induction of lung cancer by NNK is mainly achieved through the following pathways: (1) Induces gene mutation; NNK is metabolized to NNAL by the action of CYP450 enzymes to induce DNA damage; (2) Activates α7 nicotine acetylcholine receptor and promotes cell proliferation, metastasis, angiogenesis, and reduce apoptosis in LC cells; (3) Regulates gene expression through DNA-methyltransferase1 (DNMT-1, a key enzyme mediating DNA methylation, is known to be elevated in various cancers) mediated epigenetic modifications; (4) Activates TxAS/TxA2/TP/PI3K/AKT/CREB and β-AR/arachidonic acid signaling pathways; (5) Induces immune suppression [16]. Therefore, it can be seen that tobacco carcinogens are one of the key factors to induce the occurrence and development of lung cancer.
Chemoprevention is becoming more and more important in lung cancer treatment. Epidemiology analysis suggests that lung cancer can be effectively prevented through daily diet adjustments [17]. The conventional treatments of lung cancer, such as surgery, radiotherapy, and chemotherapy, can reduce tumor sizes and inhibit the cancer cell growth but cannot cause complete regression. Meanwhile, immunosuppression and the effects of cancer itself lead to low life expectancy after these treatments [18]. Chemoprevention by natural or synthetic chemicals through reducing the exposure to tobacco carcinogens could lower the risk [19]. Nature offers many safe, effective, and affordable products, usually called “phytochemicals” for various diseases [20]. For example, researchers found a significant correlation between cruciferous vegetables and organic sulfur compounds-rich species such as garlic and reduced lung cancer risk [21,22]. In addition, vitamin-rich fruits such as oranges have potential chemoprotective effects on lung cancer [23,24]. Besides, some dietary natural products such as particular food groups and nutrients have attracted much attention due to their cancer prevention in the past decades. It is worth mentioning that AACR CANCER PROGRESS REPORT 2022 emphasizes that eating at least 30 g fiber and at least 400 g of fruit and vegetables each day could decrease cancer risk in humans. Therefore, the consumption of dietary natural products to prevent lung cancer seems to be an effective strategy. Moreover, lung cancer prevention, especially for dietary chemoprevention, has been paid more and more attention in recent years. With the aim of studying chemopreventive strategies, a wide variety of murine model systems have been developed. Among several strains of mice tested, the A/J mouse strain is very susceptible to developing lung tumorigenesis, with the incidence of spontaneous and induced lung tumors at the highest rate of 61% [25,26]. It has been reported that A/J mice are more sensitive to tobacco carcinogens than other species of mice. In addition, A/J mice develop spontaneous tumors even in the absence of a carcinogen stimulus [27]. Thus, the A/J mouse model of lung cancer induced by tobacco carcinogens such as NNK or BaP is widely used in lung cancer chemoprevention [28].
Based on the above, this review aims to analyze those research studies focusing on the chemopreventive effects of dietary phytochemicals on NNK or BaP-induced lung carcinogenesis (see Figure 1 and Table 1) and to summarize the clinical trials of phytochemicals (see Table 2). We also discuss the chemopreventive mechanisms of listed dietary natural resources on lung cancer. To achieve this goal, we first obtained the related studies published in the last 20 years, mainly using Google Scholar, PubMed, and Web of Science databases. The search words included “Phytochemicals” OR “fruits and vegetables” OR “beverages” OR “species” AND “Lung cancer” AND “cigarette smoking” AND “NNK” OR “BaP” OR “nicotine”. The search is limited to in vivo studies.

2. Chemoprevention of Lung Cancer by Dietary Phytochemicals

Dietary natural products such as medicine plants, beverages, fruits, vegetables, spices and other plants possess anti-inflammatory, anti-oxidative, anti-proliferative, and cancer inhibitory activities, which have attracted much attention in the past decades. This section focuses on lung cancer chemoprevention properties of these dietary resources and the active compounds in vivo (chemical structures see Table 3).

2.1. Medicine Plants

Medicinal plants have been used in many countries as a source of primary healthcare since ancient times because of their effectiveness and low cost, as well as lesser side effects than many modern treatments [104]. Some traditional Chinese medicines are also considered as “drug homologous foods” for developing health products, such as glycyrrhiza, haskap berry, emblica, and psoralea. These “drug homologous foods” are effective in lung cancer prevention.

2.1.1. Glycyrrhiza

In both traditional Ayurvedic and Chinese medicine, Glycyrrhiza glabra L. is commonly referred to as Mulaithi and Yashtimadu, and is used to treat a variety of illnesses. Abundant components are present in Glycyrrhiza glabra L., such as flavanones, chalcones, isoflavans, isoflavenes, flavones, and isoflavones. The flavonoid lipochalcone A (LicA), isolated from Glycyrrhiza uralensis Fisch, is a potent pharmacological agent with a wide spectrum of activities. Among NNK-induced A/J mice, LicA can reverse the expression of NNK-induced miRNA miR-144-3P, miR-20a-5P, miR-29c-3P, let-7d-3p and miR-328-3p, to play a chemical prevention role in lung cancer [29]. Glycyrrhizin, a triterpenoid saponin isolated from glycyrrhiza, reversed high level of High Mobility Group Box 1 (HMGB1), which is a protein that regulates nucleosome formation and gene transcription. In addition, glycyrrhizin decreased the activity of JAk/KSTAT signing pathway in PDX mice [30]. Glycyrrhizin plus cisplatin or glycyrrhizin alone all reduced the expression of thromboxane synthase (TxAs) and PCNA in nude mice [31,32]. Proliferative cell nuclear antigen (PCNA) is necessary for DNA synthesis and DNA repair. In conclusion, as potential phytochemical Glycyrrhiza glabra L. has the potential to be a health product. The mechanism of licorice and its extracts or monomers in treating diseases is not completely clear, and it is too early for licorice to enter the clinical frontline as a low toxic, effective and controllable drug. However, as a health product or placebo, it has great commercial potential.

2.1.2. Haskap Berry

Lonicera caerulea L., also known as haskap, is a fruit, commonly planted in Asia, Canada and Eastern Europe. It is also well known by the Japanese aborigines as the “elixir of life”. Haskap berry is rich in ingredients of phenolic acids and flavonoids, especially anthocyanins. Increasing evidence has suggested that haskap berry can prevent the lung tumorigenesis. BEAS-2B cells pre-treatment with the anthocyanin-rich haskap berry extracts significantly reduced 4-[(acetoxymethyl) nitrosamino]-1-(3-pyridyl)-1-butanone (NNKOAc), a precursor of NNK, which could induce DNA damage [105]. About 79–92% of the anthocyanin content of haskap berries is composed of cyanidin-3-O-glucoside (C3G). C3G shows significant antioxidant, cardio-protective, anti-inflammatory, neuroprotective, anticancer, and anti-diabetic properties [106]. It is documented that NNK-induced A/J mice treated with C3G could markedly decrease the expression of PCNA and Ki-67 in lung tissues [33]. In an experiment of C3G plus 5-FU (a commonly used basic chemotherapy drug) in nude mice against lung cancer, the inflammatory cytokine, IL-1β, IL-6 and TNF-α, COX-2, NF-kpa and PCNA was decreased [34]. Due to this, haskap berry, especially its major component C3G, may be a promising dietary supplement or nutraceutical for suppressing lung cancer development among high-risk populations. However, this is limited to animal experiments and is still a long way from the clinic. Its future use may still be limited.

2.1.3. Emblic

Phyllanthus emblica L. (PEL), also named emblic, is a medical plant, which has been used extensively in Asia. Investigations have shown that PEL possesses a wide range of phytochemicals including tannins, polyphenols, gallic acid, flavonoids and vitamin C. Bioactivity studies revealed that PEL has a variety of biological activities, including anti-cancer. Wang and others found that the PEL extracts significantly reduced the number of BaP-induced A/J mice lung surface nodes. PEL extracts regulated the IL-1β/miR-i101/Lin28B signaling pathway for lung cancer prevention [35]. PEL exhibits anticancer activity against lung cancer, and is worth further study as a possible chemopreventive and anti-invasive agent.

2.1.4. Psoralea

Psoralea, also named Psoralea corylifolia L., is a traditional medicine used in ancient Egypt and China for various ailments such as psoriasis, vitiligo, hair loss, impotence, osteoporosis, etc. Phytochemical studies showed that psoralea mainly contains coumarins, flavones, monoterpenes, chalcones, lipids, resins, and stigmasteroids. 8-methoxsalen (8-MOP) is a furocoumarinisolated from this plant. Laboratory studies showed its effectiveness in chemoprevention of lung cancer Regarding the chemopreventive properties, 8-MOP was demonstrated to inhibit the CYP2A5-mediated metabolic activation of NNK in the mouse lung, leading to the prevention of NNK-induced adenoma [36,37,38]. However, 8-MOP in the diet of post-initiation phase does not prevent mouse lung carcinogenesis [107]. This effect is also confirmed in C57BL/6 mice that are induced by NNK [39]. In conclusion, 8-MOP is a strong chemopreventive agent for NNK-induced lung tumorigenesis.

2.2. Beverages

2.2.1. Tea

Tea (Camellia sinensis) is a popular beverage worldwide. Most of the tea is consumed in America and green tea is mainly consumed in Asian countries. Tea may help reduce the risk of cardiovascular disease, anti-hypertensive effects, body weight control, antibacterial activity, anti-fibrotic properties, solar ultra violet protection, and neuroprotective power. (-)-epigallocatechin-3-gallate (EGCG) and caffeine are main active components in tea. EGCG, the major catechin found in tea, has the potential to impact a variety of human diseases. A/J mice treatment with EGCG could weaken the elevation of DNMT1 and inhibit lung tumorigenesis triggered by NNK [40]. Tea, coffee, and soft drinks are the most important caffeine sources and energy beverages. Caffeine in tea plays an important role in preventing tumorigenesis. It is reported that administration of caffeine could inhibit the developmentof lung adenoma into adenocarcinoma in NNK-induced A/J mice [41]. Caffeine 680 ppm significantly lowered the incidence of lung tumors from 47% to 10% in F344 rats [42]. Natural polyphenols are organic chemicals thatcontain phenol units in their structures. Polymeric black tea polyphenols (PBPs) are the most abundant polyphenolic component in black tea. Several laboratory studies have confirmed the lung cancer preventive properties of PBPs. Administration of PBPs inhibited cell proliferation rate and the progression of adenoma to adenocarcinoma in adenomas of NNK-induced A/J female mice [43]. In addition, PBPs have chemopreventive effects in NNK- and BaP-induced A/J mice possibly via modulation of p38 and Akt to inhibit inflammation and cellular proliferation and to induce apoptosis [44]. In addition, PBPs decreased BPDE-DNA adducts and inhibited carcinogen-induced phase-I enzymes of lung lesions in A/J mice [45]. Polyphenon E is a green tea polyphenol preparation that contains 65% EGCG, significantly reducing the incidence and multiplicity of adenocarcinoma, similarly to PBPs [41]. Polyphenon E plus atorvastatin, or polyphenon E alone both lowered tumor incidence and tumor burden of lung carcinogens. However, atorvastatin alone only decreased tumor burden not tumor multiplicity [46]. This means the effects of lung cancer prevention maybe contributed to by polyphenon E [48]. NNK-treated mice using green tea containing drinking water (2%) significantly decreased lung tumors per mouse and inhibited the increase of 8-OH-dGuo levels in mouse lung DNA [49]. 0.3% green tea extracts also reduced tumor nodes and decreased PD-L1 positive cells in lung tumors of A/J mice [50]. White tea extracts also significantly lowered the level of ROS and lipid peroxidation (LPO) [51]. Catechin hydrate is a mixture of gallocatechingallate and epigallocatechingallate. Compared with BaP group, catechin hydrate + BaP group reduced Bcl-2, Bax and Capase-3 expression in lung tissues [47]. Tea, especially for PBPs, maybe a promising product in the area of health. As one of the beverages that people have the longest contact with in their life, tea has relatively more preventive effects on lung cancer among all the plants that have been studied. However, the exact preventive mechanism of tea is still unclear, but as a food, it is worth more use.

2.2.2. Kava

Kava

Kava is the extract of the roots of Piper methysticum. It has been consumed safely as a beverage in the South Pacific islands for centuries. According to some reports, it has anti-cancer and anti-anxiety effects. Our group has carried out continuous chemoprevention studies on kava for lung cancer. The results displayed that dietary kava led to statistically significant lower lung tumor multiplicities in NNK plus BaP-treated A/J mice [55]. It is worth mentioning that diets containing kava reduced lung adenomas multiplicity by approximately 99%. Furthermore, daily gavage of kava blocked lung adenoma formation by decreasing DNA damage in lung tissues of O6-methylguanine (O6-mG) [52]. Moreover, mice that were fed diets containing kava suppressed lung tumorigenesis in A/J mice via inhibition of cell proliferation, enhancing apoptosis, and also inhibiting the activation of NF-κB [53]. In addition, kava and its component methysticin suppressed NF-κB activation in lung adenoma tissues with minimum toxicity [56]. However, a three-day kava pretreatment potentiated acetaminophen-induced hepatotoxicity increasing severity of liver lesions, resulting from the cytotoxicity of chalcone compounds in kava [54,57]. In a clinical trial to evaluate the effects of kava on NNK metabolism, kava increased urinary excretion of total NNAL and reduced urinary 3-methyladenine (3-mA) [101].

Dihydromethysticin

Dihydromethysticin (DHM) is one of the active ingredients in kava. DHM had a dose-dependent chemical prevention effect on NNK-induced lung adenoma. DHM could reduce the formation of O6-mG and increase urinary excretion of NNK detoxification metabolites [58]. However, another study found that DHM does not affect NNAL formation and does not inhibit NNAL bioactivation. However, DHM remarkably increased O-glucuronidated NNAL in an NNK-induced model [59]. Synthetic DHM decreased adenoma multiplicity by 97% in NNK-induced A/J mice, which effects were equal to natural DHM, and it reduced DNA adducts in lung tissues [60]. The in vivo structure-activity relationship study found that the unnatural enantiomer of DHM was more potent than the natural enantiomer in NNK-induced A/J mice. More importantly, DHM analogues with high structural similarity show distinct efficacy in reducing NNK-induced DNA damage [61]. Moreover, it was determined that the methylenedioxy functional group in DHM that effectively reduced O6-mG adducts formation was critical to the chemopreventive activity and the lactone of DHM could be modified [61,62]. It was also found that DHM decreased the level of O6-mG in female C57BL/6 mice. However, in the backgrounds of Ahr+/− and Ahr−/−, there is no difference inO6-mG, indicating that AhR is not the upstream target for DHM [64]. In a recent study, DHM was found to suppress the activation of protein A (PKA) pathway induced by NNK [63]. Kava and its compounds need more attention to explore their effects in lung cancer. Kava, especially DHM, plays an obvious role in the prevention of lung cancer in mice, but its role in the prevention of lung cancer in patients with a high risk of lung cancer needs to be further studied.

2.3. Fruits

2.3.1. Citrus

5-Demethylnobiletin

Citrus is the most eaten fruit. This fruit is thought to decrease the risk of degenerative diseases and cancer. Active phytochemical constituents of this plant have been revealed so far, namely, limonene, β-caryophyllene, geranial edulinine, ribalinine, 5-demethylnobiletin, and nobiletin. 5-Demethylnobiletin is a unique citrus flavonoid with various beneficial bioactivities. Song et al. first confirmed that dietary intake of 5-demethylnobiletin remarkably inhibited tumorigenesis in NNK-induced mice, and this effect possibly was due to the metabolites of 5-demethylnobiletin in lung tissues [65].

Nobiletin

Nobiletin, a major component of citrus polymethoxy flavones, has anti-cancer effects [108]. Nobiletin inhibited CYP enzymes involved in the metabolic activation for preventing lung cancer [66]. In NNK-treated mice, oral nobiletin significantly suppressed lung tumorigenesis and decreased tumor volume [67].

Other Compounds

Limonin is a dietary phytochemical, which has been reported to possess many biological activities. Limonin supplements significantly decreased lipid peroxidation, serum marker enzymes and inflammatory cytokine levels in BaP-treated mice, and increased the nonenzymatic and enzymatic antioxidant levels, showing an effective lung cancer prevention [68]. β-Cryptoxanthin (BCX) is an oxygenated carotenoid and abundant in oranges, peaches, and pumpkins. BCX inhibited lung tumorigenesis through the down-regulation of α7-nAChR/PI3K signaling in NNK-induced A/J mice [69]. In addition, in the same lung cancer model, dietary intake of BCX restored the expressions of lung SIRT1, p53, and RAR-β, and decreased the levels of phosphorylate AKT and lung IL-6 mRNA to increase the survival probability in NNK-induced A/J mice [70]. Hesperetin and naringenin are the most abundant flavonoids in citrus fruits and possess various effects on different diseases. Hesperetin possesses a wide array of pharmacological effects which include cancer prevention [109]. Both hesperetin and naringenin effectively suppressed lung carcinoma and the associated preneoplastic lesions in a BaP-induced model by decreasing the expression of NF-kB, PCNA and CYP1A1 [71,110]. Moreover, hesperidin attenuates mitochondrial dysfunction during BaP-induced lung carcinogenesis in mice [72]. Citrus is one of the most commonly eaten fruits in daily life. According to the current literature the role of lung cancer prevention is currently documented only in animal experiments, and there is no literature to support the effects of low doses. Therefore, in life, for the purpose of preventing lung cancer, it can be appropriate to eat more of this fruit.

2.3.2. Tomatoes

Tomatoes are a good source of health-promoting phytochemicals, including phenolic compounds, lycopene, vitamins and glycoalkaloids. Lycopene is a naturally occurring carotenoid in tomatoes, tomato products and other red fruits as well as vegetables. Among smokers, dietary intake of lycopene has a strong connection with the risk of lung cancer. Rakic et al. found that dietary lycopene effectively inhibited chronic bronchitis and preneoplastic lesions in a ferret model of cigarette smoke (CS)-induced lung cancer. Moreover, lycopene feeding suppressed the accumulation of total cholesterol. Besides, dietary lycopene increased mRNA expressions of critical genes related to the reverse cholesterol transport (RCT) in the lung [73]. Similarly, lycopene is protective against NNK/CS induced lung lesions and pulmonary cholesterol homeostasis through the restoration of the impaired RCT [74]. Lycopene supplementation could inhibit α7 nicotinic acetylcholine receptor’s expression in NNK-induced mice. Moreover, it attenuated the mortality and pathological lesions in the lung [75]. The lycopene was converted to apo-10′-lycopenoids, which dose-dependently decreased the lung tumor multiplicity in NNK-induced A/J mouse model [76]. Similarly, anti-carcinogenic and antioxidant functions of apo-10′-lycopenoids were mediated by inducing phase II detoxifying/antioxidant enzymes as well as activating the expression of Nrf2 [111]. Apo-14′-lycopenoic acid is the lycopene eccentric cleavage product. Apo-10′-lycopenoic acid and apo-14′-lycopenoic acid decreased cigarette smoke extract-induced ROS production, 8-OH-dGuo formation and COX-2 expressions [112]. All these nicotine-induced structural changes in lungs of offspring mice were prevented by supplementing the mother’s diet with tomato juice [113]. Tomatoes can be eaten as either fruit or vegetable, and based on the current literature, there seems to be no risk of toxicity when consumed in moderation. In a word, tomato as a common fruit offers health benefits in daily life.

2.3.3. Grape

The grape contains various phenolic compounds, flavonoids and stilbenes. Many components in grapes have chemopreventive effects on lung cancer. For example, resveratrol is an important phenolic component in grapes. It has been reported that resveratrol exhibited a 27% reduction in tumor multiplicity, resulting in a 45% decrease in tumor per mice in NNK-induced A/J mice [77]. Resveratrol also prevented BaP-induced CYP1A1 expression [78]. Ellagic acid (EA) is produced by hydrolysis of ellagitannins, which is present in fruit berries and grapes. It has been reported that EA decreased ATP levels, reduced HIF-1α and activated AMP-activated protein kinase (AMPK) in lung tissues [114]. EA down-regulated the level of cancerous inhibitor of protein phosphatase 2A (CIP2A) in tumor-bearing mice [115]. 2,6-dimethoxy-1,4-benzoquinone (DBQ) was isolated from Vitis coignetiae (crimson glory vine, also named yamabudo in Japan). Yamabudo-juice or DBQ showed chemopreventive effects on lung tumors in NNK-induced mice. Investigation of the anti-tumorigenic mechanisms of yamabudo juice and DBQ indicated they reduced methyl DNA adducts and accelerated DNA repair. In addition, yamabudo juice and DBQ could suppress the signaling of Akt, Erk and Stat3 [79]. Grape seed proanthocyanidins (GSPs) are promising phytochemicals that have anti-inflammatory and anti-cancer effects [116]. Researchers proved GSPs inhibited the growth of lung tumor xenografts in nude mice; this effect was connected with the reduction of Bax, capase-3 [80]. Moreover, GSPs also reduced radiation damage to normal lung tissues and also regulated the expression of Ki-76, p53,Il-6 and TNF-α [117]. In short, grapes can be more used in life for whatever aim. Grapes are a common fruit and are also used as raw materials for wine. Grapes did not seem to have much of a protective effect against lung cancer, which may be partly due to the way resveratrol was administered. As a fruit, however, there seems to be no harm in eating more of it in daily life.

2.4. Vegetables

2.4.1. Cruciferous Vegetables

Phenethyl Isothiocyanate

Cruciferous vegetables have been traditionally consumed in the human diet as fresh and preserved vegetables, vegetable oils, and condiments since ancient times. 2-Phenethyl isothiocyanate (PEITC) is a natural product found in cruciferous vegetables. Various biological activities of PEITC have been explored. PEITC can induce detoxifying enzymes such as GST. Additionally, it can inhibit CYP450 involved in metabolic activation of carcinogens [118]. In the matter of lung cancer prevention, treatment with PEITC inhibited lung carcinogenesis in NNK-exposed mice [119,120]. PEITC could inhibit NNK-induced lung tumors by suppressing metabolic activation of NNK and inhibiting α-hydroxylation of NNAL in lung tissues of male F344 rats [81]. Moreover, dietary PEITC decreased the incidence of alveolar atypical and the expression of COX-2 and PCNA [82]. In a clinical trial, the NNK metabolic activation ratio was reduced after PEITC treatment in 82 smokers [102]. Similarly, Boldry et al. reported the effect of PEITC on the metabolism of carcinogen 1,3-butadiene in current smokers. The results revealed PEITC treatment is protective in respect of the detoxification of 1,3-butadiene in cigarette smokers [103]. Other compounds, including sulforaphane and sulforaphane-N-acetylcysteine, have been documented the chemopreventive efficacy on lung cancer. Dietary sulforaphane-N-acetylcysteine significantly reduced the incidence of lung tumors. Furthermore, the malignant lung tumor multiplicity was significantly reduced with dietary sulforaphane and sulforaphane-N-acetylcysteine in NNK-induced A/J mice by decreasing PCNA and capase-3 [121].

Indole-3-Carbinol

Indole-3-carbinol (I3C) is a constituent in Brassica vegetables. I3C is reported to reduce the tumor multiplicity and the level of tumor-associated signature proteins, such as apolipoprotein A-1, a-antitrypsin precursor and transferrin [83]. In NNK induced A/J mice, I3C decreased tumor burden and size by inhibiting PI3K/Akt signaling [84]. Given dietary I3C, in NNK plus BaP-treated mice, I3C showed a dose-dependent inhibition of lung tumor per mouse. Furthermore, I3C restrained the expression of PCNA, p-Akt as well as the number of Ki-67–positive cells [85]. Moreover, I3C has also been reported in combination with other compounds to prevent lung cancer. For example, a given combination of PEITC-N-acetylcysteine (NAC) and I3C could effectively reduce tumor multiplicity in NNK plus BaP induced A/J mice. The combination treatments could reduce the activation of Akt and NF-kB in lung tumor tissues that were pretreated with cigarette smoke (CSC) condensate [122]. In addition, previous research indicates that the mixtures of I3C and silibinin are much stronger than the individual compounds in A/J mice [123]. The cruciferous plant family is one of the most studied in the field of lung cancer prevention. However, it seems to have no effect on cancer treatment. It may be used in combination with chemoradiotherapy drugs in the future to reduce the side effects of chemoradiotherapy drugs to a certain extent.

2.4.2. Cucurbitaceae

Cucurbitacin B

The major crop species of cucurbitaceae family are cucumber, melon and watermelon. The chemical constituents of cucurbitaceae mainly include terpenoids, glycosides, alkaloids, saponins, tannins, etc. Cucurbitacin B (CuB) is one of the major terpenoids in cucurbitaceae plant. CuB could suppress both DNMTs and histone deacetylase as well as inhibit tumor incidence and multiplicity in A/J mice [86]. Meanwhile, Hua et al. confirmed the protective effect of CuB on lung function. CuB effectively improved the pulmonary gas exchange function, reduced pulmonary edema, and inhibited the inflammatory response by reducing the level of TNF-α and IL-6 in lung tissues [124].

2.5. Spices

2.5.1. Garlic

Garlic (Allium sativum L.), belonging to genus allium in the Liliaceae family, is native to central Asia and is widely cultivated around the world. It has been used to heal various diseases, including leprosy, cancer, constipation, asthma, and fever. Garlic has abundant bioactive chemical compounds, such as diallyl sulfide (DAS), diallyl disulfide (DADS) and diallyl trisulfide (DATS). All of these compounds have been reported to have the effects of anti-carcinogenesis [125]. Several studies have revealed the chemoprevention of DAS in lung cancer. Hong et al. found that DAS significantly lowered the incidence of lung tumors and the tumor multiplicity in A/J mice that carcinogens induced. DAS also inhibited the metabolism of NNK in lung microsomes [87]. Oral DAS also decreased tumor marker enzymes and recovered antioxidant enzymes, SOD and CAT in mice [90]. Investigation by Kong et al. revealed that oral DAS partially could reverse parts of the mitochondrial metabolic pathways, global methylation and transcriptomic changes [88]. Moreover, DAS inhibited CYP enzymes activation for inhibiting the bioactivation of NNK in A/J mice of lung tissues [89]. DAS inhibited pulmonary adenoma formation and increased glutathione S-transferase [126]. DATS and DADS induced apoptosis by increasing DNA fragmentation and activating C-Jun N-terminal kinase (JNK), up-regulating p53, and down-regulating Bcl-2 expression [127]. In DATS treated lung cancer cells it was found that Bax and Bak proteins are critical targets [128]. Garlic oil is thought to be bioactive in garlic. Our group recently screened the inhibitory effects of garlic oil on NNK treated A/J mice. The results displayed that garlic oil increases the level of the phase II drug-metabolizing enzymes for inhibiting the NNK-induced lung cancer [7].

2.5.2. Chilli

Capsaicin, a component of red chilli and red pepper, has been found to have various effects, including anti-cancer. Capsaicin could inhibit the process of lung carcinogenesis by inducing apoptosis, increasing DNA fragmentation, up-regulating the expressions of p53, Bax and decreasing the level of Bcl-2 in BaP-induced in Swiss albino mice [92]. Capsaicin also reversed BaP-induced increase of extracellular matrix components and proteases [93]. Capsaicin induced apoptosis in lung cancer cells was mediated via the TRPV6 receptor as well as inversed oxidative stress in mice administered with BaP [94,129]. Moreover, capsaicin decreased lung mitochondrial lipid peroxidation in Bap-induced lung cancer Swiss albino mice. More importantly, capsaicin augmented the activities of enzymic and non-enzymic antioxidants, citric acid cycle enzymes and respiratory chain enzymes to near normalcy [130]. Previous studies have also found that capsaicin supplementation in lung cancer bearing mice considerably prevented the increaseof TNF-α, IL-6, COX-2 and NF-κB [91].

2.5.3. Zingiber

Ginger, the rhizome of Zingiber officinalis, is one of the most widely used species in Asia. Phytochemical studies revealed that ginger is rich in chemicals including 6-shogaol, β-Elemene, Zerumbone and so on. Zerumbone, presented in subtropical ginger Zingiber zerumbet Smith, is reported to have anti-cancer properties. In the process of lung cancer induced by NNK, administration of Zerumbone restrained the multiplicity of lung adenomas through inhibition of proliferation and induction of apoptosis. These effects mainly resulted from suppression of NF-κB, HO-1 expression in lung tissues [95]. 6-shogaol is a major component of dry ginger. It increases cAMP concentration, limits NF-κB signaling and produces pro-inflammatory cytokines in activated CD4 cells to attenuate house dust mite antigen mediated lung inflammation in mice [131].

2.5.4. Turmeric

Curcumin is a constituent present in Curcuma longa L. (turmeric) rhizome. It has been used as a spice for cooking in Asia for many years. It has been reported that curcumin has chemopreventive effect on lung cancer. The average number of tumor nodules present in the lungs of the Swiss albino mice induced by BaP was significantly higher than in mice that received both a 2% curcumin diet and BaP. Furthermore, a curcumin diet lowered BaP-induced activation of NF-κB, MAPK signaling and COX-2 transcription in lung tissues of A/J mice [96]. Similarly, dietary curcumin reduced BaP-induced DNA adduct, oxidative damage and inflammation [132]. In a word, a series of spices such as garlic, ginger, pepper and turmeric is present in daily diets and living habits, but their smell is strong and will be disliked by some people. Moreover, it is not certain whether excessive consumption will have toxicity.

2.6. Other Plants

Flax has a long history of use as a food, medicine, and textile fiber. Chikara et al. found that flaxseed consumption could protect against both NNK and BaP induced lung tumor formation in A/J mice lung tissues. The effects mainly include upregulating the expression of phase II enzymes and downregulating the expression of proinflammatory cytokines [97]. Houttuynia cordata Thunb (HCT) is a commonly used herbal medicine in Asian countries, with anti-inflammatory and anti-bacterial effects. In BaP-induced A/J mice, HCT extracts activated the Nrf2-HO-1/NQO-1 signaling pathway. It also has the function of relieving intracellular ROS generation to attenuate DNA damage and inflammation induced by BaP stimulation [98]. Camptosorus sibiricus Rupr (CSR) is a commonly used herbal medicine which has anti-tumor effects. CSR extracts prevented lung tumorigenesis by acting against ROS and DNA damage in BaP-induced A/J mice [99]. Fermented brown rice and rice bran have chemopreventive effects on carcinogenesis in the colon, liver and stomach. For lung cancer prevention, both fermented brown rice and rice bran inhibited NNK-induced pulmonary tumorigenesis in A/J mice. This effect is mainly through reducing the expression of mRNA levels of CYP4502A5 [100].

3. Future Directions

Overall, this review highlights phytochemicals as potential chemopreventive agents against lung cancer. Accumulating evidence reveals that many dietary natural resources and their bioactive ingredients are able to prevent tobacco related lung cancer. Mechanically, dietary phytochemicals mainly achieved the chemoprevention of tobacco carcinogens induced lung tumorigenesis by regulating phase II metabolizing enzymes and reducing DNA adducts as summarized in Figure 2. Additionally, dietary phytochemicals are able to target and reverse epigenetic changes caused by environmental exposure, which may be due to their high potency, lower toxicity, safety, and cost-effectiveness. It is promising that the development of treatments based on the consumption of natural phytochemicals for cancer chemoprevention will produce more positive outcomes in the future, and offer the possibility of reducing cancer risk in society. An increasing number of studies have demonstrated that a large number of dietary phytochemicals can be used alone or in combination with traditional chemotherapeutic drugs to prevent the cancer initiation and metastatic spread. Rational usage of dietary phytochemicals may reduce the side effects of chemotherapy drugs. Therefore, dietary phytochemicals could be useful supplements to enhance chemotherapeutic outcomes and benefit lung cancer patients, especially providing a lung cancer prevention strategy for people at risk of developing cancer, both those who smoke and those exposed to second-hand smoke over the long term. However, it is essential to explore the potential mechanisms of action of various dietary components in combination with chemotherapies.
In addition to the advantage in lung cancer prevention, dietary chemopreventive phytochemicals still have some bottlenecks. Up to now, PEITC and Kava have been used in clinical experiments, but the results are not satisfactory, and the role in lung cancer prevention has not achieved the expected results. Potential chemopreventive phytochemicals have not yet shown significant clinical effects in preventing lung cancer progression in humans. Moreover, high concentrations of phytochemicals for long-term use may be toxic to humans. Note must be taken of biological differences, metabolic conversion, transport mechanisms, tissue availability in the metabolization of the compounds, and their bioavailability. Therefore, it is too early to draw conclusions about their chemoprevention effect. It is plausible to develop large-scale, randomized, double-blinded, placebo-controlled clinical trials before their use in the treatment of cancer. In the future, the chemopreventive efficacy of dietary phytochemicals on lung cancer should be further investigated.

Author Contributions

All authors contributed to the design and content of this review. Y.D. conceptualized the study, conceived and implemented the literature search strategy, and finally drafted the manuscript. Z.Q. supported, checked, and revised the article content. Z.Q. and C.Z. supervised, coordinated, and supplemented the study. Y.D. had primary responsibility for the final content, and all authors read and approved the final manuscript. The corresponding author attests that all listed authors meet authorship criteria and that no others meeting the criteria have been omitted. All authors have read and agreed to the published version of the manuscript.

Funding

This work was funded by grants from the Key Research and Development Program of Ningxia (2021BEG03103), the Shanghai Shuguang Program (21SG038), and West Light Foundation of the Chinese Academy of Sciences (XAB2020YW15).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

The data in this study are available upon reasonable upon reasonable request.

Conflicts of Interest

The authors declare no competing financial interests.

Abbreviations

AhRAryl hydrocarbon receptor
BaPBenzo[a]pyrene
CSCigarette smoke
CuBCucurbitacin B
C3GCyanidin-3-O-glucoside
CYP450Cytochrome P450
DADSDiallyl disulfide
DASDiallyl sulfide
DATSDiallyl trisulfide
DHMDihydromethysticin
DNMT1DNA methyltransferase 1
EGFREpidermal growth factor receptor
EAEllagic acid
HMGB1High Mobility Group Box 1
LicALicochalconeA
LPOLipid peroxidation
NSCLCNon–small-cell lung cancer cells
O6-mGO6-methylguanine
PTXPaclitaxel
PELPhyllanthusemblica L.
PBPsPolymeric black tea polyphenols
PD-L1Programmed cell death ligand 1
PCNAProliferative cell nuclear antigen
RCTReverse cholesterol transport
DBQ2,6-dimethoxy-1,4-benzoquinone
PEITC2-Phenethyl isothiocyanate
EGCGD2R,3R6-methoxycarbonylgallocatechin-3-O-gallate
3-mA3-methyladenine
NNK4-(N-methyl-N-nitrosamine)-1-(3-pyridyl)-butanone
NNAL4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol
NNKOAc4-[(acetoxymethyl) nitrosamino]-1-(3-pyridyl)-1-butanone
8-MOP8-methoxsalen
BCXβ-Cryptoxanthin
EGCG(-)-epigallocatechin-3-gallate

References

  1. Sung, H.; Ferlay, J.; Siegel, R.L.; Laversanne, M.; Soerjomataram, I.; Jemal, A.; Bray, F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J. Clin. 2021, 71, 209–249. [Google Scholar] [CrossRef] [PubMed]
  2. Lu, T.; Yang, X.; Huang, Y.; Zhao, M.; Li, M.; Ma, K.; Yin, J.; Zhan, C.; Wang, Q. Trends in the incidence, treatment, and survival of patients with lung cancer in the last four decades. Cancer Manag. Res. 2019, 11, 943–953. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  3. Siegel, R.L.; Miller, K.D.; Fuchs, H.E.; Jemal, A. Cancer statistics, 2022. CA Cancer J. Clin. 2022, 72, 7–33. [Google Scholar] [CrossRef] [PubMed]
  4. Sun, K.X.; Zheng, R.S.; Zeng, H.M.; Zhang, S.W.; Zou, X.N.; Gu, X.Y.; Xia, C.F.; Yang, Z.X.; Li, H.; Chen, W.Q.; et al. [The incidence and mortality of lung cancer in China, 2014]. Zhonghua Zhong Liu Za Zhi [Chin. J. Oncol. ] 2018, 40, 805–811. [Google Scholar] [CrossRef] [PubMed]
  5. Cooper, W.A.; Lam, D.C.; O’Toole, S.A.; Minna, J.D. Molecular biology of lung cancer. J. Thorac. Dis. 2013, 5 (Suppl. S5), S479–S490. [Google Scholar] [CrossRef] [PubMed]
  6. Pozza, D.H.; Andrade de Mello, R.B. Treatment Sequencing Strategies in Lung Cancer. Zhongguo Fei Ai Za Zhi = Chin. J. Lung Cancer 2022, 25, 323–336. [Google Scholar] [CrossRef]
  7. Zhang, L.; Qu, Z.; Song, A.; Yang, J.; Yu, J.; Zhang, W.; Zhuang, C. Garlic oil blocks tobacco carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)-induced lung tumorigenesis by inducing phase II drug-metabolizing enzymes. Food Chem. Toxicol. 2021, 157, 112581. [Google Scholar] [CrossRef]
  8. Wang, Y.; Bian, T.; Song, L.; Jiang, Y.; Huo, Z.; Salloum, R.G.; Warren, G.W.; Kaye, F.J.; Fujioka, N.; Jin, L.; et al. Reducing Chemotherapy-Induced DNA Damage via nAChR-Mediated Redox Reprograming-A New Mechanism for SCLC Chemoresistance Boosted by Nicotine. Cancers 2022, 14, 2272. [Google Scholar] [CrossRef]
  9. Bethune, G.; Bethune, D.; Ridgway, N.; Xu, Z. Epidermal growth factor receptor (EGFR) in lung cancer: An overview and update. J. Thorac. Dis. 2010, 2, 48–51. [Google Scholar]
  10. Cheng, W.L.; Chen, K.Y.; Lee, K.Y.; Feng, P.H.; Wu, S.M. Nicotinic-nAChR signaling mediates drug resistance in lung cancer. J. Cancer 2020, 11, 1125–1140. [Google Scholar] [CrossRef] [Green Version]
  11. Vu, T.; Jin, L.; Datta, P.K. Effect of Cigarette Smoking on Epithelial to Mesenchymal Transition (EMT) in Lung Cancer. J. Clin. Med. 2016, 5, 44. [Google Scholar] [CrossRef]
  12. Petrulis, J.R.; Perdew, G.H. The role of chaperone proteins in the aryl hydrocarbon receptor core complex. Chem.-Biol. Interact. 2002, 141, 25–40. [Google Scholar] [CrossRef]
  13. Tchou-Wong, K.-M.; Jiang, Y.; Yee, H.; LaRosa, J.; Lee, T.C.; Pellicer, A.; Jagirdar, J.; Gordon, T.; Goldberg, J.D.; Rom, W.N. Lung-Specific Expression of Dominant-Negative Mutant p53 in Transgenic Mice Increases Spontaneous and Benzo(a)pyrene-Induced Lung Cancer. Am. J. Respir. Cell Mol. Biol. 2002, 27, 186–193. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  14. Liskova, A.; Stefanicka, P.; Samec, M.; Smejkal, K.; Zubor, P.; Bielik, T.; Biskupska-Bodova, K.; Kwon, T.K.; Danko, J.; Büsselberg, D.; et al. Dietary phytochemicals as the potential protectors against carcinogenesis and their role in cancer chemoprevention. Clin. Exp. Med. 2020, 20, 173–190. [Google Scholar] [CrossRef] [PubMed]
  15. Wei, B.; Blount, B.C.; Xia, B.; Wang, L. Assessing exposure to tobacco-specific carcinogen NNK using its urinary metabolite NNAL measured in US population: 2011–2012. J. Expo. Sci. Environ. Epidemiol. 2016, 26, 249–256. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  16. Ge, G.-Z.; Xu, T.-R.; Chen, C. Tobacco carcinogen NNK-induced lung cancer animal models and associated carcinogenic mechanisms. Acta Biochim. Biophys. Sin. 2015, 47, 477–487. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  17. Radziszewska, A.; Karczmarek-Borowska, B.; Gradalska-Lampart, M.; Filip, A.A. Epidemiology, prevention and risk morbidity factors for lung cancer. Pol. Merkur. Lek. Organ Pol. Tow. Lek. 2015, 38, 113–118. [Google Scholar]
  18. Polanski, J.; Jankowska-Polanska, B.; Rosinczuk, J.; Chabowski, M.; Szymanska-Chabowska, A. Quality of life of patients with lung cancer. OncoTargets Ther. 2016, 9, 1023–1028. [Google Scholar] [CrossRef] [Green Version]
  19. Kasala, E.R.; Bodduluru, L.N.; Barua, C.C.; Sriram, C.S.; Gogoi, R. Benzo(a)pyrene induced lung cancer: Role of dietary phytochemicals in chemoprevention. Pharmacol. Rep. 2015, 67, 996–1009. [Google Scholar] [CrossRef]
  20. Forni, C.; Facchiano, F.; Bartoli, M.; Pieretti, S.; Facchiano, A.; D’Arcangelo, D.; Norelli, S.; Valle, G.; Nisini, R.; Beninati, S.; et al. Beneficial Role of Phytochemicals on Oxidative Stress and Age-Related Diseases. BioMed Res. Int. 2019, 2019, 8748253. [Google Scholar] [CrossRef] [Green Version]
  21. Wang, C.; Yang, T.; Guo, X.F.; Li, D. The Associations of Fruit and Vegetable Intake with Lung Cancer Risk in Participants with Different Smoking Status: A Meta-Analysis of Prospective Cohort Studies. Nutrients 2019, 11, 1791. [Google Scholar] [CrossRef] [Green Version]
  22. Lam, T.K.; Gallicchio, L.; Lindsley, K.; Shiels, M.; Hammond, E.; Tao, X.; Chen, L.; Robinson, K.A.; Caulfield, L.E.; Herman, J.G.; et al. Cruciferous Vegetable Consumption and Lung Cancer Risk: A Systematic Review. Cancer Epidemiol. Biomark. Prev. 2009, 18, 184–195. [Google Scholar] [CrossRef] [PubMed]
  23. García-Lavandeira, J.A.; Ruano-Ravina, A.; Torres-Durán, M.; Parente-Lamelas, I.; Provencio, M.; Varela-Lema, L.; Fernández-Villar, A.; Piñeiro, M.; Barros-Dios, J.M.; Pérez-Ríos, M. Fruits and Vegetables and Lung Cancer Risk in Never Smokers. A Multicentric and Pooled Case-Control Study. Nutr. Cancer 2022, 74, 613–621. [Google Scholar] [CrossRef] [PubMed]
  24. Vieira, A.R.; Abar, L.; Vingeliene, S.; Chan, D.S.M.; Aune, D.; Navarro-Rosenblatt, D.; Stevens, C.; Greenwood, D.; Norat, T. Fruits, vegetables and lung cancer risk: A systematic review and meta-analysis. Ann. Oncol. 2016, 27, 81–96. [Google Scholar] [CrossRef] [PubMed]
  25. de Seranno, S.; Meuwissen, R. Progress and applications of mouse models for human lung cancer. Eur. Respir. J. 2010, 35, 426. [Google Scholar] [CrossRef] [Green Version]
  26. Witschi, H. The complexities of an apparently simple lung tumor model: The A/J mouse. Exp. Toxicol. Pathol. Off. J. Ges. Fur Toxikol. Pathol. 2005, 57 (Suppl. S1), 171–181. [Google Scholar] [CrossRef] [PubMed]
  27. Witschi, H. A/J Mouse As A Model For Lung Tumorigenesis Caused By Tobacco Smoke: Strengths And Weaknesses. Exp. Lung Res. 2004, 31, 3–18. [Google Scholar] [CrossRef]
  28. Zheng, H.C.; Takano, Y. NNK-Induced Lung Tumors: A Review of Animal Model. J. Oncol. 2011, 2011, 635379. [Google Scholar] [CrossRef] [Green Version]
  29. Li, B.; Zhou, D.; Li, S.; Feng, Y.; Li, X.; Chang, W.; Zhang, J.; Sun, Y.; Qing, D.; Chen, G.; et al. Licochalcone A reverses NNK-induced ectopic miRNA expression to elicit in vitro and in vivo chemopreventive effects. Phytomedicine 2020, 76, 153245. [Google Scholar] [CrossRef]
  30. Wu, X.; Wang, W.; Chen, Y.; Liu, X.; Wang, J.; Qin, X.; Yuan, D.; Yu, T.; Chen, G.; Mi, Y.; et al. Glycyrrhizin Suppresses the Growth of Human NSCLC Cell Line HCC827 by Downregulating HMGB1 Level. Biomed. Res. Int. 2018, 2018, 6916797. [Google Scholar] [CrossRef] [Green Version]
  31. Deng, Q.P.; Wang, M.J.; Zeng, X.; Chen, G.G.; Huang, R.Y. Effects of Glycyrrhizin in a Mouse Model of Lung Adenocarcinoma. Cell. Physiol. Biochem. 2017, 41, 1383–1392. [Google Scholar] [CrossRef] [PubMed]
  32. Huang, R.Y.; Chu, Y.L.; Jiang, Z.B.; Chen, X.M.; Zhang, X.; Zeng, X. Glycyrrhizin Suppresses Lung Adenocarcinoma Cell Growth Through Inhibition of Thromboxane Synthase. Cell. Physiol. Biochem. 2014, 33, 375–388. [Google Scholar] [CrossRef]
  33. Amararathna, M.; Hoskin, D.W.; Rupasinghe, H.P.V. Cyanidin-3-O-Glucoside-Rich Haskap Berry Administration Suppresses Carcinogen-Induced Lung Tumorigenesis in A/JCr Mice. Molecules 2020, 25, 3823. [Google Scholar] [CrossRef] [PubMed]
  34. Wu, C.-F.; Wu, C.-Y.; Lin, C.-F.; Liu, Y.-W.; Lin, T.-C.; Liao, H.-J.; Chang, G.-R. The anticancer effects of cyanidin 3-O-glucoside combined with 5-fluorouracil on lung large-cell carcinoma in nude mice. Biomed. Pharmacother. 2022, 151, 113128. [Google Scholar] [CrossRef]
  35. Wang, C.C.; Yuan, J.R.; Wang, C.F.; Yang, N.; Chen, J.; Liu, D.; Song, J.; Feng, L.; Tan, X.B.; Jia, X.B. Anti-inflammatory Effects of Phyllanthus emblica L. on Benzopyrene-Induced Precancerous Lung Lesion by Regulating the IL-1beta/miR-101/Lin28B Signaling Pathway. Integr. Cancer 2017, 16, 505–515. [Google Scholar] [CrossRef]
  36. Takeuchi, H.; Saoo, K.; Yokohira, M.; Ikeda, M.; Maeta, H.; Miyazaki, M.; Yamazaki, H.; Kamataki, T.; Imaida, K. Pretreatment with 8-methoxypsoralen, a potent human CYP2A6 inhibitor, strongly inhibits lung tumorigenesis induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in female A/J mice. Cancer Res. 2003, 63, 7581–7583. [Google Scholar] [PubMed]
  37. Takeuchi, H.; Saoo, K.; Matsuda, Y.; Yokohira, M.; Yamakawa, K.; Zeng, Y.; Kuno, T.; Kamataki, T.; Imaida, K. 8-Methoxypsoralen, a potent human CYP2A6 inhibitor, inhibits lung adenocarcinoma development induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in female A/J mice. Mol. Med. Rep. 2009, 2, 585–588. [Google Scholar] [CrossRef] [Green Version]
  38. Takeuchi, H.; Saoo, K.; Matsuda, Y.; Yokohira, M.; Yamakawa, K.; Zeng, Y.; Miyazaki, M.; Fujieda, M.; Kamataki, T.; Imaida, K. Dose dependent inhibitory effects of dietary 8-methoxypsoralen on NNK-induced lung tumorigenesis in female A/J mice. Cancer Lett. 2006, 234, 232–238. [Google Scholar] [CrossRef]
  39. Feng, M.; Zhang, H.; Cao, B.; Liu, S.; Mao, J.; Zhang, Q. Effects of 8-methoxypsoralen on the metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in mice. Drug Metab. Pharm. 2015, 30, 314–320. [Google Scholar] [CrossRef]
  40. Jin, H.; Chen, J.X.; Wang, H.; Lu, G.; Liu, A.; Li, G.; Tu, S.; Lin, Y.; Yang, C.S. NNK-induced DNA methyltransferase 1 in lung tumorigenesis in A/J mice and inhibitory effects of (-)-epigallocatechin-3-gallate. Nutr. Cancer 2015, 67, 167–176. [Google Scholar] [CrossRef] [Green Version]
  41. Lu, G.; Liao, J.; Yang, G.; Reuhl, K.R.; Hao, X.; Yang, C.S. Inhibition of adenoma progression to adenocarcinoma in a 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis model in A/J mice by tea polyphenols and caffeine. Cancer Res. 2006, 66, 11494–11501. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  42. Chung, F.-L.; Wang, M.; Rivenson, A.; Iatropoulos, M.J.; Reinhardt, J.C.; Pittman, B.; Ho, C.-T.; Amin, S.G. Inhibition of Lung Carcinogenesis by Black Tea in Fischer Rats Treated with a Tobacco-specific Carcinogen: Caffeine as an Important Constituent1. Cancer Res. 1998, 58, 4096–4101. [Google Scholar] [PubMed]
  43. Yang, G.-y.; Wang, Z.-Y.; Kim, S.; Liao, J.; Seril, D.N.; Chen, X.; Smith, T.J.; Yang, C.S. Characterization of Early Pulmonary Hyperproliferation and Tumor Progression and Their Inhibition by Black Tea in a 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced Lung Tumorigenesis Model with A/J Mice1. Cancer Res. 1997, 57, 1889–1894. [Google Scholar] [PubMed]
  44. Hudlikar, R.R.; Venkadakrishnan, V.B.; Kumar, R.; Thorat, R.A.; Kannan, S.; Ingle, A.D.; Desai, S.; Maru, G.B.; Mahimkar, M.B. Polymeric black tea polyphenols (PBPs) inhibit benzo(a)pyrene and 4-(methylnitrosamino)-1-(3-pyridyl)-1- butanone-induced lung carcinogenesis potentially through down-regulation of p38 and Akt phosphorylation in A/J mice. Mol. Carcinog. 2016, 56, 625–640. [Google Scholar] [CrossRef]
  45. Hudlikar, R.R.; Pai, V.; Kumar, R.; Thorat, R.A.; Kannan, S.; Ingle, A.D.; Maru, G.B.; Mahimkar, M.B. Dose-Related Modulatory Effects of Polymeric Black Tea Polyphenols (PBPs) on Initiation and Promotion Events in B(a)P and NNK-Induced Lung Carcinogenesis. Nutr. Cancer 2019, 71, 508–523. [Google Scholar] [CrossRef] [PubMed]
  46. Lu, G.; Xiao, H.; You, H.; Lin, Y.; Jin, H.; Snagaski, B.; Yang, C.S. Synergistic Inhibition of Lung Tumorigenesis by a Combination of Green Tea Polyphenols and Atorvastatin. Clin. Cancer Res. 2008, 14, 4981–4988. [Google Scholar] [CrossRef] [Green Version]
  47. Khattab, S.A.; Hussien, W.F.; Raafat, N.; Ahmed Alaa El-Din, E. Effects of catechin hydrate in benzo[a]pyrene-induced lung toxicity: Roles of oxidative stress, apoptosis, and DNA damage. Toxicol. Mech. Methods 2021, 31, 467–475. [Google Scholar] [CrossRef]
  48. Liao, J.; Yang, G.Y.; Park, E.S.; Meng, X.; Sun, Y.; Jia, D.; Seril, D.N.; Yang, C.S. Inhibition of lung carcinogenesis and effects on angiogenesis and apoptosis in A/J mice by oral administration of green tea. Nutr. Cancer 2004, 48, 44–53. [Google Scholar] [CrossRef]
  49. Xu, Y.; Ho, C.-T.; Amin, S.G.; Han, C.; Chung, F.-L. Inhibition of Tobacco-specific Nitrosamine-induced Lung Tumorigenesis in A/J Mice by Green Tea and Its Major Polyphenol as Antioxidants1. Cancer Res. 1992, 52, 3875–3879. [Google Scholar] [PubMed]
  50. Rawangkan, A.; Wongsirisin, P.; Namiki, K.; Iida, K.; Kobayashi, Y.; Shimizu, Y.; Fujiki, H.; Suganuma, M. Green Tea Catechin Is an Alternative Immune Checkpoint Inhibitor that Inhibits PD-L1 Expression and Lung Tumor Growth. Molecules 2018, 23, 2071. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  51. Dhatwalia, S.K.; Kumar, M.; Bhardwaj, P.; Dhawan, D.K. White tea—A cost effective alternative to EGCG in fight against benzo(a)pyrene (BaP) induced lung toxicity in SD rats. Food Chem. Toxicol. 2019, 131, 110551. [Google Scholar] [CrossRef] [PubMed]
  52. Leitzman, P.; Narayanapillai, S.C.; Balbo, S.; Zhou, B.; Upadhyaya, P.; Shaik, A.A.; O’Sullivan, M.G.; Hecht, S.S.; Lu, J.; Xing, C. Kava blocks 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis in association with reducing O6-methylguanine DNA adduct in A/J mice. Cancer Prev. Res. 2014, 7, 86–96. [Google Scholar] [CrossRef] [PubMed]
  53. Johnson, T.E.; Hermanson, D.; Wang, L.; Kassie, F.; Upadhyaya, P.; O’Sullivan, M.G.; Hecht, S.S.; Lu, J.; Xing, C. Lung tumorigenesis suppressing effects of a commercial kava extract and its selected compounds in A/J mice. Am. J. Chin. Med. 2011, 39, 727–742. [Google Scholar] [CrossRef] [PubMed]
  54. Bian, T.; Corral, P.; Wang, Y.; Botello, J.; Kingston, R.; Daniels, T.; Salloum, R.G.; Johnston, E.; Huo, Z.; Lu, J.; et al. Kava as a Clinical Nutrient: Promises and Challenges. Nutrients 2020, 12, 3044. [Google Scholar] [CrossRef]
  55. Johnson, T.E.; Kassie, F.; O’Sullivan, M.G.; Negia, M.; Hanson, T.E.; Upadhyaya, P.; Ruvolo, P.P.; Hecht, S.S.; Xing, C. Chemopreventive Effect of Kava on 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone plus Benzo[a]pyrene–Induced Lung Tumorigenesis in A/J Mice. Cancer Prev. Res. 2008, 1, 430–438. [Google Scholar] [CrossRef] [Green Version]
  56. Shaik, A.A.; Hermanson, D.L.; Xing, C. Identification of methysticin as a potent and non-toxic NF-kappaB inhibitor from kava, potentially responsible for kava’s chemopreventive activity. Bioorg. Med. Chem Lett. 2009, 19, 5732–5736. [Google Scholar] [CrossRef] [Green Version]
  57. Narayanapillai, S.C.; Leitzman, P.; O’Sullivan, M.G.; Xing, C. Flavokawains A and B in Kava, Not Dihydromethysticin, Potentiate Acetaminophen-Induced Hepatotoxicity in C57BL/6 Mice. Chem. Res. Toxicol. 2014, 27, 1871–1876. [Google Scholar] [CrossRef] [Green Version]
  58. Hu, Q.; Corral, P.; Narayanapillai, S.C.; Leitzman, P.; Upadhyaya, P.; O’Sullivan, M.G.; Hecht, S.S.; Lu, J.; Xing, C. Oral Dosing of Dihydromethysticin Ahead of Tobacco Carcinogen NNK Effectively Prevents Lung Tumorigenesis in A/J Mice. Chem. Res. Toxicol. 2020, 33, 1980–1988. [Google Scholar] [CrossRef]
  59. Narayanapillai, S.C.; von Weymarn, L.B.; Carmella, S.G.; Leitzman, P.; Paladino, J.; Upadhyaya, P.; Hecht, S.S.; Murphy, S.E.; Xing, C. Dietary Dihydromethysticin Increases Glucuronidation of 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanol in A/J Mice, Potentially Enhancing Its Detoxification. Drug Metab. Dispos. 2016, 44, 422–427. [Google Scholar] [CrossRef] [Green Version]
  60. Narayanapillai, S.C.; Balbo, S.; Leitzman, P.; Grill, A.E.; Upadhyaya, P.; Shaik, A.A.; Zhou, B.; O’Sullivan, M.G.; Peterson, L.A.; Lu, J.; et al. Dihydromethysticin from kava blocks tobacco carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis and differentially reduces DNA damage in A/J mice. Carcinogenesis 2014, 35, 2365–2372. [Google Scholar] [CrossRef] [Green Version]
  61. Hati, S.; Hu, Q.; Huo, Z.; Lu, J.; Xing, C. In vivo Structure-Activity Relationship of Dihydromethysticin in Reducing Nicotine-Derived Nitrosamine Ketone (NNK)-Induced Lung DNA Damage against Lung Carcinogenesis in A/J Mice. ChemMedChem 2022, 17, e202100727. [Google Scholar] [CrossRef]
  62. Puppala, M.; Narayanapillai, S.C.; Leitzman, P.; Sun, H.; Upadhyaya, P.; O’Sullivan, M.G.; Hecht, S.S.; Xing, C. Pilot in Vivo Structure-Activity Relationship of Dihydromethysticin in Blocking 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone-Induced O(6)-Methylguanine and Lung Tumor in A/J Mice. J. Med. Chem. 2017, 60, 7935–7940. [Google Scholar] [CrossRef] [PubMed]
  63. Bian, T.; Ding, H.; Wang, Y.; Hu, Q.; Chen, S.; Fujioka, N.; Aly, F.Z.; Lu, J.; Huo, Z.; Xing, C. Suppressing the activation of protein kinase A as a DNA damage-independent mechanistic lead for dihydromethysticin (DHM) prophylaxis of NNK-induced lung carcinogenesis. Carcinogenesis 2022, 43, 659–670. [Google Scholar] [CrossRef] [PubMed]
  64. Narayanapillai, S.C.; Lin, S.H.; Leitzman, P.; Upadhyaya, P.; Baglole, C.J.; Xing, C. Dihydromethysticin (DHM) Blocks Tobacco Carcinogen 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)-Induced O(6)-Methylguanine in a Manner Independent of the Aryl Hydrocarbon Receptor (AhR) Pathway in C57BL/6 Female Mice. Chem. Res. Toxicol. 2016, 29, 1828–1834. [Google Scholar] [CrossRef] [PubMed]
  65. Song, M.; Wu, X.; Charoensinphon, N.; Wang, M.; Zheng, J.; Gao, Z.; Xu, F.; Li, Z.; Li, F.; Zhou, J.; et al. Dietary 5-demethylnobiletin inhibits cigarette carcinogen NNK-induced lung tumorigenesis in mice. Food Funct. 2017, 8, 954–963. [Google Scholar] [CrossRef] [PubMed]
  66. Ikeda, M.; Masumura, K.-i.; Matsui, K.; Kohno, H.; Sakuma, K.; Tanaka, T.; Nohmi, T. Chemopreventive Effects of Nobiletin against Genotoxicity Induced by 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in the Lung of gpt delta Transgenic Mice. Genes Environ. 2006, 28, 84–91. [Google Scholar] [CrossRef] [Green Version]
  67. Sun, Y.; Han, Y.; Song, M.; Charoensinphon, N.; Zheng, J.; Qiu, P.; Wu, X.; Xiao, H. Inhibitory effects of nobiletin and its major metabolites on lung tumorigenesis. Food Funct. 2019, 10, 7444–7452. [Google Scholar] [CrossRef] [PubMed]
  68. Gong, C.; Qi, L.; Huo, Y.; Zhang, S.; Ning, X.; Bai, L.; Wang, Z. Anticancer effect of Limonin against benzo(a)pyrene-induced lung carcinogenesis in Swiss albino mice and the inhibition of A549 cell proliferation through apoptotic pathway. J. Biochem. Mol. Toxicol. 2019, 33, e22374. [Google Scholar] [CrossRef]
  69. Iskandar, A.R.; Miao, B.; Li, X.; Hu, K.Q.; Liu, C.; Wang, X.D. beta-Cryptoxanthin Reduced Lung Tumor Multiplicity and Inhibited Lung Cancer Cell Motility by Downregulating Nicotinic Acetylcholine Receptor alpha7 Signaling. Cancer Prev. Res. 2016, 9, 875–886. [Google Scholar] [CrossRef] [Green Version]
  70. Iskandar, A.R.; Liu, C.; Smith, D.E.; Hu, K.Q.; Choi, S.W.; Ausman, L.M.; Wang, X.D. beta-cryptoxanthin restores nicotine-reduced lung SIRT1 to normal levels and inhibits nicotine-promoted lung tumorigenesis and emphysema in A/J mice. Cancer Prev. Res. 2013, 6, 309–320. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  71. Bodduluru, L.N.; Kasala, E.R.; Barua, C.C.; Karnam, K.C.; Dahiya, V.; Ellutla, M. Antiproliferative and antioxidant potential of hesperetin against benzo(a)pyrene-induced lung carcinogenesis in Swiss albino mice. Chem.-Biol. Interact. 2015, 242, 345–352. [Google Scholar] [CrossRef] [PubMed]
  72. Kamaraj, S.; Anandakumar, P.; Jagan, S.; Ramakrishnan, G.; Devaki, T. Hesperidin attenuates mitochondrial dysfunction during benzo(a)pyrene-induced lung carcinogenesis in mice. Fundam. Clin. Pharm. 2011, 25, 91–98. [Google Scholar] [CrossRef] [PubMed]
  73. Mustra Rakic, J.; Liu, C.; Veeramachaneni, S.; Wu, D.; Paul, L.; Chen, C.O.; Ausman, L.M.; Wang, X.D. Lycopene Inhibits Smoke-Induced Chronic Obstructive Pulmonary Disease and Lung Carcinogenesis by Modulating Reverse Cholesterol Transport in Ferrets. Cancer Prev. Res. 2019, 12, 421–432. [Google Scholar] [CrossRef] [PubMed]
  74. Rakic, J.M.; Liu, C.; Veeramachaneni, S.; Wu, D.; Paul, L.; Chen, O.; Ausman, L.; Wang, X.-D. Modulation of Reverse Cholesterol Transport by Lycopene Is Associated with Its Protective Role Against Cigarette Smoke Induced COPD and Lung Carcinogenesis in Ferrets (OR05-02-19). Curr. Dev. Nutr. 2019, 3, nzz029-OR05. [Google Scholar] [CrossRef] [Green Version]
  75. Aizawa, K.; Liu, C.; Tang, S.; Veeramachaneni, S.; Hu, K.Q.; Smith, D.E.; Wang, X.D. Tobacco carcinogen induces both lung cancer and non-alcoholic steatohepatitis and hepatocellular carcinomas in ferrets which can be attenuated by lycopene supplementation. Int. J. Cancer 2016, 139, 1171–1181. [Google Scholar] [CrossRef] [Green Version]
  76. Lian, F.; Smith, D.E.; Ernst, H.; Russell, R.M.; Wang, X.D. Apo-10′-lycopenoic acid inhibits lung cancer cell growth in vitro, and suppresses lung tumorigenesis in the A/J mouse model in vivo. Carcinogenesis 2007, 28, 1567–1574. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  77. Monteillier, A.; Voisin, A.; Furrer, P.; Allemann, E.; Cuendet, M. Intranasal administration of resveratrol successfully prevents lung cancer in A/J mice. Sci. Rep. 2018, 8, 14257. [Google Scholar] [CrossRef] [Green Version]
  78. Revel, A.; Raanani, H.; Younglai, E.; Xu, J.; Rogers, I.; Han, R.; Savouret, J.F.; Casper, R.F. Resveratrol, a natural aryl hydrocarbon receptor antagonist, protects lung from DNA damage and apoptosis caused by benzo[a]pyrene. J. Appl. Toxicol. 2003, 23, 255–261. [Google Scholar] [CrossRef]
  79. Arimoto-Kobayashi, S.; Sasaki, K.; Hida, R.; Miyake, N.; Fujii, N.; Saiki, Y.; Daimaru, K.; Nakashima, H.; Kubo, T.; Kiura, K. Chemopreventive effects and anti-tumorigenic mechanisms of 2,6-dimethoxy-1,4-benzoquinone, a constituent of Vitis coignetiae Pulliat (crimson glory vine, known as yamabudo in Japan), toward 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)-induced lung tumorigenesis in A/J mice. Food Chem. Toxicol. 2021, 154, 112319. [Google Scholar] [CrossRef]
  80. Akhtar, S.; Meeran, S.M.; Katiyar, N.; Katiyar, S.K. Grape Seed Proanthocyanidins Inhibit the Growth of Human Non-Small Cell Lung Cancer Xenografts by Targeting Insulin-Like Growth Factor Binding Protein-3, Tumor Cell Proliferation, and Angiogenic Factors. Clin. Cancer Res. 2009, 15, 821–831. [Google Scholar] [CrossRef] [Green Version]
  81. Staretz, M.E.; Koenig, L.A.; Hecht, S.S. Effects of long term dietary phenethyl isothiocyanate on the microsomal metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in F344 rats. Carcinogenesis 1997, 18, 1715–1722. [Google Scholar] [CrossRef] [PubMed]
  82. Ye, B.; Zhang, Y.X.; Yang, F.; Chen, H.L.; Xia, D.; Liu, M.Q.; Lai, B.T. Induction of lung lesions in Wistar rats by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and its inhibition by aspirin and phenethyl isothiocyanate. BMC Cancer 2007, 7, 90. [Google Scholar] [CrossRef] [PubMed]
  83. Kassie, F.; Anderson, L.B.; Scherber, R.; Yu, N.; Lahti, D.; Upadhyaya, P.; Hecht, S.S. Indole-3-carbinol inhibits 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone plus benzo(a)pyrene-induced lung tumorigenesis in A/J mice and modulates carcinogen-induced alterations in protein levels. Cancer Res. 2007, 67, 6502–6511. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  84. Qian, X.; Melkamu, T.; Upadhyaya, P.; Kassie, F. Indole-3-carbinol inhibited tobacco smoke carcinogen-induced lung adenocarcinoma in A/J mice when administered during the post-initiation or progression phase of lung tumorigenesis. Cancer Lett. 2011, 311, 57–65. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  85. Kassie, F.; Matise, I.; Negia, M.; Upadhyaya, P.; Hecht, S.S. Dose-dependent inhibition of tobacco smoke carcinogen-induced lung tumorigenesis in A/J mice by indole-3-carbinol. Cancer Prev. Res. 2008, 1, 568–576. [Google Scholar] [CrossRef] [Green Version]
  86. Shukla, S.; Khan, S.; Kumar, S.; Sinha, S.; Farhan, M.; Bora, H.K.; Maurya, R.; Meeran, S.M. Cucurbitacin B Alters the Expression of Tumor-Related Genes by Epigenetic Modifications in NSCLC and Inhibits NNK-Induced Lung Tumorigenesis. Cancer Prev. Res. 2015, 8, 552–562. [Google Scholar] [CrossRef] [Green Version]
  87. Hong, J.-Y.; Wang, Z.Y.; Smith, T.J.; Zhou, S.; Shi, S.; Pan, J.; Yang, C.S. Inhibitory effects of diallyl sulfide on the metabolism and tumorigenicity of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in A/J mouse lung. Carcinogenesis 1992, 13, 901–904. [Google Scholar] [CrossRef]
  88. Hudlikar, R.R.; Sargsyan, D.; Cheng, D.; Kuo, H.D.; Wu, R.; Su, X.; Kong, A.N. Tobacco carcinogen 4-[Methyl(nitroso)amino]-1-(3-pyridinyl)-1-butanone (NNK) drives metabolic rewiring and epigenetic reprograming in A/J mice lung cancer model and prevention with Diallyl Sulphide (DAS). Carcinogenesis 2022, 43, 140–149. [Google Scholar] [CrossRef]
  89. Yang, C.S.; Chhabra, S.K.; Hong, J.-Y.; Smith, T.J. Mechanisms of Inhibition of Chemical Toxicity and Carcinogenesis by Diallyl Sulfide (DAS) and Related Compounds from Garlic. J. Nutr. 2001, 131, 1041S–1045S. [Google Scholar] [CrossRef] [Green Version]
  90. Khan, A.; Alhumaydhi, F.A.; Alwashmi, A.S.S.; Allemailem, K.S.; Alsahli, M.A.; Alrumaihi, F.A.; Almatroudi, A.; Mobark, M.A.; Mousa, A.; Khan, M.A. Diallyl Sulfide-Mediated Modulation of the Fatty Acid Synthase (FASN) Leads to Cancer Cell Death in BaP-Induced Lung Carcinogenesis in Swiss Mice. J. Inflamm. Res. 2020, 13, 1075–1087. [Google Scholar] [CrossRef]
  91. Anandakumar, P.; Kamaraj, S.; Jagan, S.; Ramakrishnan, G.; Asokkumar, S.; Naveenkumar, C.; Raghunandhakumar, S.; Devaki, T. Capsaicin inhibits benzo(a)pyrene-induced lung carcinogenesis in an in vivo mouse model. Inflamm. Res. 2012, 61, 1169–1175. [Google Scholar] [CrossRef] [PubMed]
  92. Anandakumar, P.; Kamaraj, S.; Jagan, S.; Ramakrishnan, G.; Devaki, T. Capsaicin provokes apoptosis and restricts benzo(a)pyrene induced lung tumorigenesis in Swiss albino mice. Int. Immunopharmacol. 2013, 17, 254–259. [Google Scholar] [CrossRef] [PubMed]
  93. Anandakumar, P.; Kamaraj, S.; Jagan, S.; Ramakrishnan, G.; Asokkumar, S.; Naveenkumar, C.; Raghunandhakumar, S.; Vanitha, M.K.; Devaki, T. The Anticancer Role of Capsaicin in Experimentallyinduced Lung Carcinogenesis. J. Pharmacopunct. 2015, 18, 19–25. [Google Scholar] [CrossRef] [PubMed]
  94. Anandakumar, P.; Kamaraj, S.; Jagan, S.; Ramakrishnan, G.; Vinodhkumar, R.; Devaki, T. Capsaicin modulates pulmonary antioxidant defense system during benzo(a)pyrene-induced lung cancer in Swiss albino mice. Phytother. Res. 2008, 22, 529–533. [Google Scholar] [CrossRef] [PubMed]
  95. Kim, M.; Miyamoto, S.; Yasui, Y.; Oyama, T.; Murakami, A.; Tanaka, T. Zerumbone, a tropical ginger sesquiterpene, inhibits colon and lung carcinogenesis in mice. Int. J. Cancer 2009, 124, 264–271. [Google Scholar] [CrossRef]
  96. Puliyappadamba, V.T.; Thulasidasan, A.K.; Vijayakurup, V.; Antony, J.; Bava, S.V.; Anwar, S.; Sundaram, S.; Anto, R.J. Curcumin inhibits B[a]PDE-induced procarcinogenic signals in lung cancer cells, and curbs B[a]P-induced mutagenesis and lung carcinogenesis. Biofactors 2015, 41, 431–442. [Google Scholar] [CrossRef]
  97. Chikara, S.; Mamidi, S.; Sreedasyam, A.; Chittem, K.; Pietrofesa, R.; Zuppa, A.; Moorthy, G.; Dyer, N.; Christofidou-Solomidou, M.; Reindl, K.M. Flaxseed Consumption Inhibits Chemically Induced Lung Tumorigenesis and Modulates Expression of Phase II Enzymes and Inflammatory Cytokines in A/J Mice. Cancer Prev. Res. 2017, 11, 27–37. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  98. Lou, Y.; Guo, Z.; Zhu, Y.; Kong, M.; Zhang, R.; Lu, L.; Wu, F.; Liu, Z.; Wu, J. Houttuynia cordata Thunb. and its bioactive compound 2-undecanone significantly suppress benzo(a)pyrene-induced lung tumorigenesis by activating the Nrf2-HO-1/NQO-1 signaling pathway. J. Exp. Clin. Cancer Res. 2019, 38, 242. [Google Scholar] [CrossRef]
  99. He, S.; Ou, R.; Wang, W.; Ji, L.; Gao, H.; Zhu, Y.; Liu, X.; Zheng, H.; Liu, Z.; Wu, P.; et al. Camptosorus sibiricus rupr aqueous extract prevents lung tumorigenesis via dual effects against ROS and DNA damage. J. Ethnopharmacol 2018, 220, 44–56. [Google Scholar] [CrossRef]
  100. Phutthaphadoong, S.; Yamada, Y.; Hirata, A.; Tomita, H.; Taguchi, A.; Hara, A.; Limtrakul, P.N.; Iwasaki, T.; Kobayashi, H.; Mori, H. Chemopreventive effects of fermented brown rice and rice bran against 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis in female A/J mice. Oncol. Rep. 2009, 21, 321–327. [Google Scholar]
  101. Wang, Y.; Narayanapillai, S.C.; Tessier, K.M.; Strayer, L.G.; Upadhyaya, P.; Hu, Q.; Kingston, R.; Salloum, R.G.; Lu, J.; Hecht, S.S.; et al. The Impact of One-week Dietary Supplementation with Kava on Biomarkers of Tobacco Use and Nitrosamine-based Carcinogenesis Risk among Active Smokers. Cancer Prev. Res. 2020, 13, 483–492. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  102. Yuan, J.M.; Stepanov, I.; Murphy, S.E.; Wang, R.; Allen, S.; Jensen, J.; Strayer, L.; Adams-Haduch, J.; Upadhyaya, P.; Le, C.; et al. Clinical Trial of 2-Phenethyl Isothiocyanate as an Inhibitor of Metabolic Activation of a Tobacco-Specific Lung Carcinogen in Cigarette Smokers. Cancer Prev. Res. 2016, 9, 396–405. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  103. Boldry, E.J.; Yuan, J.M.; Carmella, S.G.; Wang, R.; Tessier, K.; Hatsukami, D.K.; Hecht, S.S.; Tretyakova, N.Y. Effects of 2-Phenethyl Isothiocyanate on Metabolism of 1,3-Butadiene in Smokers. Cancer Prev. Res. 2020, 13, 91–100. [Google Scholar] [CrossRef]
  104. Kubatka, P.; Kello, M.; Kajo, K.; Samec, M.; Jasek, K.; Vybohova, D.; Uramova, S.; Liskova, A.; Sadlonova, V.; Koklesova, L.; et al. Chemopreventive and Therapeutic Efficacy of Cinnamomum zeylanicum L. Bark in Experimental Breast Carcinoma: Mechanistic In Vivo and In Vitro Analyses. Molecules 2020, 25, 1399. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  105. Amararathna, M.; Hoskin, D.W.; Rupasinghe, H.P.V. Anthocyanin-rich haskap (Lonicera caerulea L.) berry extracts reduce nitrosamine-induced DNA damage in human normal lung epithelial cells in vitro. Food Chem. Toxicol. 2020, 141, 111404. [Google Scholar] [CrossRef]
  106. Rupasinghe, H.P.V.; Arumuggam, N.; Amararathna, M.; De Silva, A.B.K.H. The potential health benefits of haskap ( Lonicera caerulea L.): Role of cyanidin-3- O -glucoside. J. Funct. Foods 2018, 44, 24–39. [Google Scholar] [CrossRef]
  107. Kuno, T.; Yokohira, M.; Matsuda, Y.; Suzuki, S.; Hashimoto, N.; Yamakawa, K.; Saoo, K.; Imaida, K. Lack of modifying potential of 8-methoxypsoralen in the promotion or progression stages of lung carcinogenesis in A/J female mice. Oncol. Rep. 2008, 20, 767–772. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  108. Singh, A.P.; Kandpal, J.B.; Sharma, R.K.; Chitme, H. Nobiletin a Biologically Active Phytoconstituent: Systematic Review. J. Biol. Act. Prod. Nat. 2021, 11, 204–211. [Google Scholar] [CrossRef]
  109. Roohbakhsh, A.; Parhiz, H.; Soltani, F.; Rezaee, R.; Iranshahi, M. Molecular mechanisms behind the biological effects of hesperidin and hesperetin for the prevention of cancer and cardiovascular diseases. Life Sci. 2015, 124, 64–74. [Google Scholar] [CrossRef]
  110. Bodduluru, L.N.; Kasala, E.R.; Madhana, R.M.; Barua, C.C.; Hussain, M.I.; Haloi, P.; Borah, P. Naringenin ameliorates inflammation and cell proliferation in benzo(a)pyrene induced pulmonary carcinogenesis by modulating CYP1A1, NFkappaB and PCNA expression. Int. Immunopharmacol. 2016, 30, 102–110. [Google Scholar] [CrossRef]
  111. Lian, F.; Wang, X.D. Enzymatic metabolites of lycopene induce Nrf2-mediated expression of phase II detoxifying/antioxidant enzymes in human bronchial epithelial cells. Int. J. Cancer 2008, 123, 1262–1268. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  112. Catalano, A.; Simone, R.E.; Cittadini, A.; Reynaud, E.; Caris-Veyrat, C.; Palozza, P. Comparative antioxidant effects of lycopene, apo-10′-lycopenoic acid and apo-14’-lycopenoic acid in human macrophages exposed to H2O2 and cigarette smoke extract. Food Chem. Toxicol. 2013, 51, 71–79. [Google Scholar] [CrossRef] [PubMed]
  113. Maritz, G.S.; Mutemwa, M.; Kayigire, A.X. Tomato juice protects the lungs of the offspring of female rats exposed to nicotine during gestation and lactation. Pediatr. Pulmonol. 2011, 46, 976–986. [Google Scholar] [CrossRef] [PubMed]
  114. Duan, J.; Li, Y.; Gao, H.; Yang, D.; He, X.; Fang, Y.; Zhou, G. Phenolic compound ellagic acid inhibits mitochondrial respiration and tumor growth in lung cancer. Food Funct. 2020, 11, 6332–6339. [Google Scholar] [CrossRef] [PubMed]
  115. Duan, J.; Zhan, J.-C.; Wang, G.-Z.; Zhao, X.-C.; Huang, W.-D.; Zhou, G.-B. The red wine component ellagic acid induces autophagy and exhibits anti-lung cancer activity in vitro and in vivo. J. Cell. Mol. Med. 2019, 23, 143–154. [Google Scholar] [CrossRef]
  116. Alsharairi, N.A. Insights into the Mechanisms of Action of Proanthocyanidins and Anthocyanins in the Treatment of Nicotine-Induced Non-Small Cell Lung Cancer. Int. J. Mol. Sci. 2022, 23, 7905. [Google Scholar] [CrossRef]
  117. Xu, Y.; Huang, Y.; Chen, Y.; Cao, K.; Liu, Z.; Wan, Z.; Liao, Z.; Li, B.; Cui, J.; Yang, Y.; et al. Grape Seed Proanthocyanidins play the roles of radioprotection on Normal Lung and radiosensitization on Lung Cancer via differential regulation of the MAPK Signaling Pathway. J. Cancer 2021, 12, 2844–2854. [Google Scholar] [CrossRef] [PubMed]
  118. Hu, R.; Xu, C.; Shen, G.; Jain, M.R.; Khor, T.O.; Gopalkrishnan, A.; Lin, W.; Reddy, B.; Chan, J.Y.; Kong, A.N. Identification of Nrf2-regulated genes induced by chemopreventive isothiocyanate PEITC by oligonucleotide microarray. Life Sci. 2006, 79, 1944–1955. [Google Scholar] [CrossRef] [PubMed]
  119. Jiao, D.; Smith, T.J.; Yang, C.S.; Pittman, B.; Desai, D.; Amin, S.; Chung, F.L. Chemopreventive activity of thiol conjugates of isothiocyanates for lung tumorigenesis. Carcinogenesis 1997, 18, 2143–2147. [Google Scholar] [CrossRef] [Green Version]
  120. Hecht, S.S.; Trushin, N.; Rigotty, J.; Carmella, S.G.; Borukhova, A.; Akerkar, S.; Rivenson, A. Complete inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced rat lung tumorigenesis and favorable modification of biomarkers by phenethyl isothiocyanate. Cancer Epidemiol. Biomark. Prev. 1996, 5, 645–652. [Google Scholar]
  121. Conaway, C.C.; Wang, C.X.; Pittman, B.; Yang, Y.M.; Schwartz, J.E.; Tian, D.; McIntee, E.J.; Hecht, S.S.; Chung, F.L. Phenethyl isothiocyanate and sulforaphane and their N-acetylcysteine conjugates inhibit malignant progression of lung adenomas induced by tobacco carcinogens in A/J mice. Cancer Res. 2005, 65, 8548–8557. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  122. Kassie, F.; Melkamu, T.; Endalew, A.; Upadhyaya, P.; Luo, X.; Hecht, S.S. Inhibition of lung carcinogenesis and critical cancer-related signaling pathways by N-acetyl-S-(N-2-phenethylthiocarbamoyl)-l-cysteine, indole-3-carbinol and myo-inositol, alone and in combination. Carcinogenesis 2010, 31, 1634–1641. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  123. Dagne, A.; Melkamu, T.; Schutten, M.M.; Qian, X.; Upadhyaya, P.; Luo, X.; Kassie, F. Enhanced inhibition of lung adenocarcinoma by combinatorial treatment with indole-3-carbinol and silibinin in A/J mice. Carcinogenesis 2011, 32, 561–567. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  124. Hua, S.; Liu, X.; Lv, S.; Wang, Z. Protective Effects of Cucurbitacin B on Acute Lung Injury Induced by Sepsis in Rats. Med. Sci. Monit. 2017, 23, 1355–1362. [Google Scholar] [CrossRef] [PubMed]
  125. Koizumi, K.; Iwasaki, Y.; Narukawa, M.; Iitsuka, Y.; Fukao, T.; Seki, T.; Ariga, T.; Watanabe, T. Diallyl sulfides in garlic activate both TRPA1 and TRPV1. Biochem. Biophys. Res. Commun. 2009, 382, 545–548. [Google Scholar] [CrossRef] [PubMed]
  126. Sparnins, V.L.; Barany, G.; Wattenberg, L.W. Effects of organosulfur compounds from garlic and onions on benzo[ a ]pyrene-induced neoplasia and glutathione S-transferase activity in the mouse. Carcinogenesis 1988, 9, 131–134. [Google Scholar] [CrossRef] [PubMed]
  127. Wu, X.J.; Hu, Y.; Lamy, E.; Mersch-Sundermann, V. Apoptosis induction in human lung adenocarcinoma cells by oil-soluble allyl sulfides: Triggers, pathways, and modulators. Environ. Mol. Mutagen 2009, 50, 266–275. [Google Scholar] [CrossRef]
  128. Xiao, D.; Zeng, Y.; Hahm, E.R.; Kim, Y.A.; Ramalingam, S.; Singh, S.V. Diallyl trisulfide selectively causes Bax- and Bak-mediated apoptosis in human lung cancer cells. Env. Mol. Mutagen 2009, 50, 201–212. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  129. Lau, J.K.; Brown, K.C.; Dom, A.M.; Witte, T.R.; Thornhill, B.A.; Crabtree, C.M.; Perry, H.E.; Brown, J.M.; Ball, J.G.; Creel, R.G.; et al. Capsaicin induces apoptosis in human small cell lung cancer via the TRPV6 receptor and the calpain pathway. Apoptosis 2014, 19, 1190–1201. [Google Scholar] [CrossRef]
  130. Anandakumar, P.; Kamaraj, S.; Jagan, S.; Ramakrishnan, G.; Vinodhkumar, R.; Devaki, T. Stabilization of pulmonary mitochondrial enzyme system by capsaicin during benzo(a)pyrene induced experimental lung cancer. Biomed. Pharm. 2008, 62, 390–394. [Google Scholar] [CrossRef]
  131. Yocum, G.T.; Hwang, J.J.; Mikami, M.; Danielsson, J.; Kuforiji, A.S.; Emala, C.W. Ginger and its bioactive component 6-shogaol mitigate lung inflammation in a murine asthma model. Am. J. Physiol. Lung Cell. Mol. Physiol. 2020, 318, L296–L303. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  132. Garg, R.; Gupta, S.; Maru, G.B. Dietary curcumin modulates transcriptional regulators of phase I and phase II enzymes in benzo[a]pyrene-treated mice: Mechanism of its anti-initiating action. Carcinogenesis 2008, 29, 1022–1032. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Graphic summary of the dietary phytochemicals that are cancer-preventive on BaP or NNK triggered lung carcinogenesis.
Figure 1. Graphic summary of the dietary phytochemicals that are cancer-preventive on BaP or NNK triggered lung carcinogenesis.
Nutrients 15 00491 g001
Figure 2. The mechanism of phytochemical prevention of tobacco-induced lung cancer.
Figure 2. The mechanism of phytochemical prevention of tobacco-induced lung cancer.
Nutrients 15 00491 g002
Table 1. Summary of the in vivo studies describing dietary phytochemicals for lung cancer prevention.
Table 1. Summary of the in vivo studies describing dietary phytochemicals for lung cancer prevention.
Nature ProductsBioactive ComponentsClassification of CompoundsDoseModel of AnimalsEffects and MechanismsRef
GlycyrrhizaLicAMonomeric compound20 mg/KgNNK-induced A/J miceReversed NNK-induced miRNA expression[29]
GlycyrrhizaMonomeric compound100 mg/KgPDX miceInhibited the growth of lung tumor; Suppressed migration and invasion; Decreased the activity of Jak/KSTAT signaling[30]
Glycyrrhiza + cisplatinMonomeric compound135 mg/Kg + 2.5 mg/Kg
50 mg/Kg/2 d
Nude miceReduced expression of thromboxane synthase (TxAS) and PCNA; Rescued damage of liver and kidney[31,32]
Haskap berryCyanidin-3-O-glucosideMonomeric compound0.2 g/mice/dNNK-induced A/J miceReduced tumor multiplicity, tumor area, PCNA and Ki-67[33]
Cyanidin-3-O-glucoside plus 5-FUMonomeric compound5 mg/Kg + 25 mg/KgNude miceDecreased inflammatory cytokine levels, such as IL-1β,IL-6 and TNF-α; Decreased COX-2, NF-kpa, PCNA[34]
EmblicEmblicL extractsMixture5 g/kgBaP-induced A/J miceReduced the number of nodes by regulated the IL-1β/miR-i101/Lin28B signaling pathway[35]
Psoralea8-MOPMonomeric compound50/12.5 mg/KgNNK-induced A/J miceInhibited the CYP2A5-mediated metabolic activation of NNK in the mouse lung; Reduced NNK-induced tumor incidence and tumor multiplicity[36,37,38]
12.5 mg/KgNNK-induced C57BL/C miceDecreased α-hydroxylation of NNK[39]
TeaEGCGMonomeric compound0.5% dietNNK-induced A/J miceAttenuated DNMT1 and inhibited lung tumorigenesis[40]
CaffeineMonomeric compound0.044% in drinking waterNNK-induced A/J miceInhibited the progression of lung adenoma to adenocarcinoma[41]
680 ppm in drinking waterNNK-induced F344 ratsDecreased the incidence of lung tumor[42]
PBPsMixture0.3% in drinking waterNNK-induced A/J miceInhibited the progression of adenoma to adenocarcinoma and cell proliferation[43]
1.5% in drinking waterNNK- and BaP-induced A/J miceInhibited inflammation and induced apoptosis via p38 and Akt[44]
3% in drinking waterAnti-initiating and anti-promoting and inhibited the expression of CYP1A2 and increased the activity of GSTs and decreased tumor incidence and multiplicity[45]
Polyphenon EMixture0.5% in drinking waterNNK-induced A/J miceReduced the incidence and multiplicity; Inhibited cell proliferation and enhanced apoptosis and lowered levels of c-Jun and extracellular signal-regulated kinase (Erk) ½ phosphorylation[41]
Polyohenon E plus EatorvastatinMixture0.5% in drinking water + 200 ppm dietNNK-induced A/J miceSuppressed myeloid cell leukemia 1; Increasing the cleaved caspase-3 and cleaved poly (ADP)-ribose polymerase level [46]
Catechin hydrateMixture20 mg/KgBaP-induced albino ratsReduced Bcl-2, Bax and Capase-3 expression[47]
Tea preparationMixture0.6%, 2%, 0.3% in drinking waterNNK-induced A/J miceReduced lung tumor multiplicity; Inhibited angiogenesis and enhanced apoptosis index; Reduced the number of lung tumors; Inhibited the increase of 8-OH-dGuo level; Inhibited the percentage of PD-L1[48,49,50]
1% in drinking waterBap-induced SD ratsDecreased the level of ROS, LPO and NO[51]
KavaKavaMixture5 mg/g
10 mg/g
NNK-induced A/J miceReduced tumor multiplicities; Decreased O6-mG; Suppressed NF-κB; Enhanced apoptosis[52,53,54]
10 mg/gNNK plus Bap-induced A/J miceReduced PCNA; Increase in caspase-3, and cleavage of poly (ADP-ribose) polymerase (PARP); Inhibited the activation of nuclear factor κBNF-κB[55,56]
500 mg/KgAcetaminophen induced C57BL/6 miceIncreased AST and ALT; Increased severity of liver lesions[57]
DHMMonomeric compound2 mg/d
32 mg/Kg
1 mg/g
0.05 mg/g
200 ppm diet
NNK-induced A/J miceDecreased the formation of O6-mG; Increased the urinary excretion of NNK metabolites; Increased NNAL-O-glue; Decreased adenoma multiplicity; Reduced DNA adducts; Suppressed PKA pathway[58,59,60,61,62,63]
1 mg/gNNK-induced C57BL/6 miceReduced the formation of O6-mG adducts[64]
Citrus5-DemethylnobiletinMonomeric compound0.05% dietNNK-induced A/J miceDecreased lung tumor multiplicity and tumor volume[65]
NobiletinMonomeric compound500 ppm dietNNK-induced gpt delte miceInhibited CYP enzymes that involved in the metabolic activation of NNK[66]
0.05% dietNNK-induced A/J miceDecreased tumor volume; Decreased the expression level of PCNA[67]
LimoninMonomeric compound50 mg/KgBap-induced A/J miceDecreased lipid peroxidation, serum marker enzymes and inflammatory cytokines levels; Enhanced apoptosis[68]
β-CryptoxanthinMonomeric compound10 mg/KgNNK-induced A/J miceDown-regulated α7-nAChR/PI3K signaling[69]
20 mg/KgNNK-induced A/J miceRestored the nicotine-suppressed expression of lung SIRT1, p53, and RAR-β; Decreased the levels of lung il-6 mRNA and phosphorylation of AKT[70]
Hesperetin/Naringenin
/Hesperidin
Monomeric compound25 mg/Kg
50 mg/Kg
BaP-induced Swiss albino miceAlleviated LPO, modulated antioxidants and decreased the expression of NF-kB, PCNA and CYP1A1; Attenuated mitochondrial dysfunction[71,72]
TomatoLycopeneMonomeric compound6.6 mg/KgNNK/CS-induced ferretsInhibited chronic bronchitis, emphysema, and preneoplastic lesions; Increased mRNA expression of critical genes related to RCT in the lungs[73]
[74]
6.6 mg/KgNNK-induced ferretsPrevented the expression of α7 nicotinic acetylcholine receptor in the lung; Decreased the mortality rate of ferrets[75]
apo-10′-lycopenoidsMonomeric compound120 mg/KgNNK-induced A/J miceDecreased lung tumor multiplicity[76]
GrapeResveratrolMonomeric compound60 mg/KgNNK-induced A/J mice Inhibited the level of CYP450[77]
50 mg/KgBaP-induced Balb/C micePrevented CYP 1A1 expression[78]
DBQMonomeric compound0.1 g/L drinking waterNNK-induced A/J miceDecreased lipid peroxidation [79]
Grape seed proanthocyanidinsMixture0.5% dietNude miceReduce Bax, capase-3[80]
Cruciferous vegetablesPEITCMonomeric compound3 μMol/g diet
0.5 g/Kg diet
NNK-induced F344/Wistar ratsInhibited metabolic activation of NNK; inhibited lung α-hydroxylation of NNAL; Decreased COX-2 expression and PCNA expression[81,82]
I3CMonomeric compound112 mM/g diet
10 μM/g diet
NNK-induced A/J miceReduced tumor multiplicity; Reduced the level of tumor-associated signature proteins; Inhibited PI3K/Akt signaling[83,84]
112 mM/g dietNNK plus BaP-induced miceReduced the number of Ki-67–positive cells and expression of proliferating cell nuclear antigen, phospho-Akt, and phospho-BAD[85]
Cucurbitacin BMonomeric compound0.2 mg/KgNNK-induced A/J miceInhibited tumor incidence and multiplicity; Inhibited DNA methyltransferase (DNMTs) and histone deacetylase (HDACs)[86]
GarlicDASMonomeric compound200 mg/KgNNK-induced A/J miceDecreased the incidence of lung tumors and multiplicity; inhibited the metabolism of NNK in mouse lung microsomes
Reversed mitochondrial metabolic pathways, global methylation and transcriptomic changes
Inhibited the bioactivation of NNK by inhibition of other CYP enzymes active
[87,88,89]
100 mg/KgBaP-induced Swiss miceDecreased tumor marker enzymes and recovered antioxidant enzymes, SOD and CAT[90]
Garlic oilMixture50 mg/KgNNK-induced A/J miceInduced the expressions of the phase II drug-metabolizing enzymes, and HO-1[7]
ChilliCapsaicinMonomeric compound10 mg/KgBaP treated A/J micePrevented the increasing of TNF-α, IL-6, COX-2 and NF-κB[91]
10 mg/KgBaP-induced Swiss albino miceInhibited the development lung carcinogenesis; Induced apoptosis, through inducing increase DNA fragmentation and the expressions of p53, Bax and caspase-3 and decreasing the level of Bcl-2[92]
[93]
10 mg/KgInversed BaP-induced oxidative stress[94]
ZingerZerumboneMonomeric compound500 ppm dietNNK-induced A/J miceInhibited the multiplicity of lung adenomas Induced apoptosis, and suppressed NF-κB and HO-1 expression[95]
TurmericCurcuminMonomeric compound2% dietBaP-induced Swiss albino miceDecreased lung nodes; Reduced the activation of NF-κB and MAPK signaling and Cox-2 transcription[96]
FlaxFlaxseedMixture10% dietNNK-induced A/J miceReduced lung tumor incidence and multiplicity; Suppressed the phosphorylation (activation) of p-AKT, p-ERK, and p-JNK kinases[97]
HCTHCT extractsMixture50 g/KgBaP-induced A/J miceActivated the Nrf2-HO-1/NQO-1 signaling pathway intracellular ROS generation, attenuated DNA damage and inflammation[98]
CSRCSR extractsMixture3 g/KgBaP-induced A/J miceSuppressed ROS production by re-activating Nrf2-mediated reductases HO-1 and NQO-1[99]
FBRAFBRMixture10% dietNNK-induced A/J miceDecreased the expression of CYP-450 and Ki-67 positivity[100]
Table 2. Summary of the clinical trials describing dietary phytochemicals for lung cancer prevention.
Table 2. Summary of the clinical trials describing dietary phytochemicals for lung cancer prevention.
Nature ProductsBioactive ComponentsClassification of CompoundsDoseEffects and MechanismsRef
KavaKavaMixture225 mg/dIncreased urinary excretion of total NNAL; Reduced 3-mA[101]
Cruciferous vegetablesPEITCMonomeric compound10 mg dissolved in 1 ml olive oil 4 times/d, lasts 5 daysReduced NNK metabolic activation ratio; Increased urinary levels of BD-mercapturic acids[102,103]
Table 3. The representative dietary plants and phytochemicals for lung cancer prevention.
Table 3. The representative dietary plants and phytochemicals for lung cancer prevention.
PlantsThe Structure of Nature Products
Nutrients 15 00491 i001
Tea
Nutrients 15 00491 i002
Caffeine
Nutrients 15 00491 i003
EGCG
Nutrients 15 00491 i004
Kava
Nutrients 15 00491 i005
Dihydromethysticin
Nutrients 15 00491 i006Nutrients 15 00491 i007
LicA
Nutrients 15 00491 i008
Glycyrrhizin
Nutrients 15 00491 i009Nutrients 15 00491 i010
C3G
Nutrients 15 00491 i011
Psoralea corylifolia L.
Nutrients 15 00491 i012
8-MOP
Grape
Nutrients 15 00491 i013
Nutrients 15 00491 i014
Resveratrol
Nutrients 15 00491 i015
EA
Nutrients 15 00491 i016
DBQ
Citrus
Nutrients 15 00491 i017
Nutrients 15 00491 i018
5-Demethylnobiletin
Nutrients 15 00491 i019
Nobiletin
Nutrients 15 00491 i020
Limonin
Nutrients 15 00491 i021
Hesperetin
Nutrients 15 00491 i022
BCX
Nutrients 15 00491 i023
Hesperidin
Nutrients 15 00491 i024
Naringenin
Nutrients 15 00491 i025
Tomato
Nutrients 15 00491 i026
Lycopene
Cruciferous vegetables
Nutrients 15 00491 i027
Nutrients 15 00491 i028
I3C
Nutrients 15 00491 i029
PEITC
Cucurbitaceae
Nutrients 15 00491 i030
Nutrients 15 00491 i031
Cucurbitacin B
Garlic
Nutrients 15 00491 i032
Nutrients 15 00491 i033
DAS
Nutrients 15 00491 i034
DADS
Nutrients 15 00491 i035
DATS
Nutrients 15 00491 i036
Chilli
Nutrients 15 00491 i037
Capsaicin
Ginger
Nutrients 15 00491 i038
Nutrients 15 00491 i039
6-shogaol
Nutrients 15 00491 i040
Zerumbone
Turmeric
Nutrients 15 00491 i041
Nutrients 15 00491 i042
Curcumin
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Ding, Y.; Hou, R.; Yu, J.; Xing, C.; Zhuang, C.; Qu, Z. Dietary Phytochemicals as Potential Chemopreventive Agents against Tobacco-Induced Lung Carcinogenesis. Nutrients 2023, 15, 491. https://doi.org/10.3390/nu15030491

AMA Style

Ding Y, Hou R, Yu J, Xing C, Zhuang C, Qu Z. Dietary Phytochemicals as Potential Chemopreventive Agents against Tobacco-Induced Lung Carcinogenesis. Nutrients. 2023; 15(3):491. https://doi.org/10.3390/nu15030491

Chicago/Turabian Style

Ding, Yan, Ruilin Hou, Jianqiang Yu, Chengguo Xing, Chunlin Zhuang, and Zhuo Qu. 2023. "Dietary Phytochemicals as Potential Chemopreventive Agents against Tobacco-Induced Lung Carcinogenesis" Nutrients 15, no. 3: 491. https://doi.org/10.3390/nu15030491

APA Style

Ding, Y., Hou, R., Yu, J., Xing, C., Zhuang, C., & Qu, Z. (2023). Dietary Phytochemicals as Potential Chemopreventive Agents against Tobacco-Induced Lung Carcinogenesis. Nutrients, 15(3), 491. https://doi.org/10.3390/nu15030491

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop